Near-Infrared Quantum Dots For Bioimaging And Targeting Applications by Quek, Chai Hoon
 i
v 
 
 
Near-Infrared Quantum Dots For Bioimaging And Targeting 
Applications 
by 
Chai Hoon Quek 
Department of Mechanical Engineering & Materials Science 
Duke University 
 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Prof. Kam W. Leong, Supervisor 
 
___________________________ 
Prof. Piotr Marszalek 
 
___________________________ 
Prof. Stefan Zauscher 
 
___________________________ 
Prof. Mark Wiesner 
 
 
 
 
Dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor 
of Philosophy in the Department of 
Mechanical Engineering & Materials Science in the Graduate School 
of Duke University 
 
2014 
 
  
 
ABSTRACT 
Near-Infrared Quantum Dots For Bioimaging And Targeting 
Applications 
by 
Chai Hoon Quek 
Department of Mechanical Engineering & Materials Science 
Duke University 
 
 
Date:_______________________ 
Approved: 
 
___________________________ 
Prof. Kam W. Leong, Supervisor 
 
___________________________ 
Prof. Piotr Marszalek 
 
___________________________ 
Prof. Stefan Zauscher 
 
___________________________ 
Prof. Mark Wiesner 
 
 
 
 
An abstract of a dissertation submitted in partial 
fulfillment of the requirements for the degree 
of Doctor of Philosophy in the Department of 
Mechanical Engineering & Materials Science in the Graduate School of 
Duke University 
 
2014 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Chai Hoon Quek 
2014 
 
 iv 
Abstract 
A series of silver-doped zinc slelenide quantum dots were synthesized in 
aqueous medium with emission across the visible and near-infrared region. 
These QDs were evaluated in vitro with rat macrophages cell line (RAW 264.7) 
and human mesenchymal stem cells (hMSC). Viability assay indicates that these 
quantum dots have low cytotoxicity in duration of 24 h. In vivo biodistribution 
study shows that these bare QDs are different from conventional QDs, it 
traversed through systemic route and could accumulate in the stomach of nude 
mice. We performed conjugation of the QDs to monoclonal CD44v6 antibody and 
tested with human gastric adenocarcinoma cell lines found validated the 
targeting specificity property of these QDs. The QDs were also conjugated to 
heparin and used to formulate nanocomplexes with chitodan to encapsulate 
tumor necrosis factor-alpha. Quantitative imaging analysis revealed in vivo 
trafficking kinetics of the NPs to the lymph nodes after subcutaneous 
administration into nude mice. This study demonstrates the potential of 
incorporation of near-infrared-emitting QDs in nanocarrier drug delivery allows 
effective in vivo trafficking of the biodistriution events and will be of greatly 
improve the development new drug nanocarrier formulations.  
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Chapter 1 
Introduction 
 
1.1 Overview 
Nanotechnology is a fast growing field aiming to develop products that can 
possibly bring improvements to the life of human beings. Among the many 
different products created from nanotechnology, quantum dots (QDs) are the 
most widely studied and have being fabricated into several commercial 
applications such as quantum dots light emitting diodes (Colvin et al. 1994; Coe 
et al. 2002),  electronic displays (Cho et al. 2009) and solar cell panels (Schuler 
et al. 2007; Sargent 2012; Semonin et al. 2012). Recently, QDs are also gaining 
popularity in biomedical research as imaging probes due to their unique 
physiochemical and optical properties (Alivisatos et al. 2005; Zhang et al. 2008). 
They have narrow emission spectra tunable by size and/or composition 
(Alivisatos 1996), exceptional brightness and photostability (Michalet et al. 2005) 
and their surface are amenable to incorporate functional groups (Clapp et al. 
2006; Mei et al. 2009; Susumu et al. 2009).  
QDs are typically comprised of binary combination of elements from 
periodic groups of II-VI (CdSe and CdTe), III-V (InP and InAs) or IV-VI (PbS), 
affording a range of emission wavelengths from the UV to the near infrared.  To 
date, majority of quantum dots that are commercially available are CdSe, CdTe 
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and PbSe that are typically synthesized in organic solvents and high 
temperatures (Murray et al. 2000). With the implementation of the "Restriction of 
Hazardous Substances Directive" (RoHS) in February 2003 by the European 
Union and January 2007 in California, there is an increasing awareness to phase 
out the use of cadmium, lead and other heavy metal-containing quantum dots in 
the consumer products.   
To circumvent this issue, significant efforts are invested to develop safe 
alternatives to toxic metal-containing QDs (Pons et al. 2010; Park et al. 2011; 
Zhang et al. 2011). However, to our knowledge, all these reported systems are 
based on the conventional high temperature synthesis strategies. In 2007, many 
researchers were overwhelmed by the achievement of Rogach et. al. in 
developing an aqueous route to prepare thiol-capped cadmium telluride (Rogach 
et al. 2007) and set the pace for intensive research to develop green chemistry 
for producing QDs. Nonetheless, aqueous synthetic route to produce heavy 
metal-free, near-infrared emitting QDs is still lacking. We propose here to 
develop a rational green synthetic strategy to produce novel heavy metal-free 
zinc selenide (ZnSe) based QDs that will potentially can be applied to biomedical 
research. We will first explore to find a suitable hydrophilic stabilizer that will 
produce stable ZnSe QDs in aqueous phase. Once we establish the base 
conditions for the synthesis, we will utilize the doping technology commonly used 
in semiconductor production (Cao 2011) and incorporate trace amount of dopant 
into the ZnSe QDs. The findings of Peng et. al. (Chen et al. 2009; Xie et al. 2009) 
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and Zheng et. al. (Xing et al. 2008) indicated that copper dopant can be used to 
tune the emission towards higher wavelength. In this thesis, the effect of 
inclusion of salts of group 11 elements of the periodic table in the QDs synthesis 
will be investigated. After we ascertain the parameters to produce stable, visible 
to near-infrared emitting QDs, we will continue to assess its optical, structural, 
size and surface charge characteristics. Thereafter, we will perform proof-of-
concept experiments to demonstrate the versatile biomedical applications of the 
QDs the with two different model systems: (1) for specific cell labeling study 
whereby QDs conjugated with a primary monoclonal antibody will be used to 
target the surface glycoprotein CD44v6 antigen that is expressed by early gastric 
adenocarcinoma cancer cell line; (2) to probe the in vivo trafficking of QDs-
labeled drug nanocarrier in a nude mouse model. Depicted in Figure 1 is the 
overview of the specific aims of this thesis. 
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Figure 1. Overview of specific aims. The specific aims of this project will explore 
the development and characterization of a novel, heavy-metal free QDs as well 
as to evaluate their potential for biomedical applications.    
 
 
1.2 Thesis Organization 
The present work is organized in the following way. Chapter 2 will provide 
an overview of near-infrared fluorescent nanoprobes with applications specifically 
in the area of in vivo optical imaging. Succeeding chapters will show how we 
have designed new heavy-metal free QDs for bioimaging and targeting 
applications.  
Chapter 3 will discuss the synthesis of group 11 transition metal-doped 
zinc selenide quantum dots (QDs) which emit in the visible to near-infrared 
regions. The challenges faced in dopant selection, optimization of growth rate 
and emission are addressed. Optical, size and structural characterizations of 
these QDs will also be presented.  
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Chapter 4 covers the biological evaluations of the QDs. In this section, we 
sought to address (1) if the presence of QDs perturb biological function and (2) 
can the optical properties of QDs be upheld in biological environments? 
Chapter 5 will illustrate the versatility of conducting surface decoration of 
QDs with specific targeting moiety. The antibody we will use for this study is a 
primary monoclonal antibody against CD44v6 antigen. The challenge to prevent 
the conjugation at the active sites of the antibody will be discussed. The antibody 
affinity after conjugation reaction will be determined by cellular study. 
Chapter 6 will concentrate on our effort to establish the near-infrared 
emitting QDs as a nanoprobe for delivery to the lymph nodes. The challenges to 
(1) control the size of the QD-labeled nanocomplexes to below 80 nm and (2) 
scrutinize the stability of the nanocomplexes during the in vivo study will be dealt 
in this section.  
Chapter 7 then summarized the research work and highlights the unique 
properties and limitations of our approach. It also covers some of the future 
research directions that can stem from this work.  
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Chapter 2 
Near-Infrared Fluorescent Nanoprobes for in Vivo 
Optical Imaging 
 
2.1 Introduction 
The first medical imaging was realized in the late 1895 by Wilhelm 
Röntgen shortly after he discovered X-ray and applied to capturing the images of 
the bones of a hand on film (Kevles 1997). The immediate consequence of this 
discovery triggered intense development of new imaging technologies, such as 
X-ray computed tomography, magnetic resonance imaging, positron emission 
tomography, ultrasound and optical imaging, that are indispensable to diagnostic 
medicine (Table 1) (Massoud et al. 2003; Rudin et al. 2003). These imaging 
technologies differ predominantly in the following aspects: resolution, penetration 
depth, temporal resolution and energy expended for generation of the image.  
Today, these modern imaging technologies coupled with newly developed 
imaging probes are widely used in monitoring disease progression, interrogating 
cellular and molecular events, evaluating safety and toxicology in drug discovery 
and development, and assessing therapeutic efficacy in vivo (Weissleder 2001; 
Contag 2002; Weissleder 2002; Rudin et al. 2003; Gross et al. 2006; Hargreaves 
2008; Rudin 2009; Dufort et al. 2010; Koba et al. 2011; Sivaraman et al. 2011). 
Among the different imaging modalities, optical imaging, which owes its origin to 
single-cell in vitro studies, is attractive for small animal imaging because of its 
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lower cost, portability, and potentially high spatial resolution with customizable 
fine-tuning. Despite being one of the most attractive techniques to provide 
noninvasive and nonionizing in vivo visualization (Hickson 2009), optical imaging 
is impeded by the tendency of living biological tissues to absorb and scatter 
photons and generate strong autofluorescence, which interferes with signal 
collection and processing (Figure 2) (Frangioni 2003). In addition, living tissues 
also contain other major NIR absorbers, such as water, lipids oxyhemoglobin and 
deoxyhemoglobin (Weissleder 2001) that prove challenging for optical imaging. 
To overcome these barriers, intense research has focused on developing highly 
sensitive and efficient fluorescent probes that function in the biologically 
transparent window of the first and second NIR region (NIR I, 650–950 nm, and NIR 
II, 1000–1350 nm) (Figure 3) (Smith et al. 2009). Near-infrared (NIR) fluorescent 
probes offer advantages of high photon penetration, reduced light scattering and 
minimal autofluorescence from living tissues, rendering them valuable for 
noninvasive mapping of molecular events, assessment of therapeutic efficacy, 
and monitoring of disease progression in animal models. This review will provide 
a broad overview of the available NIR fluorescent probes, their optical properties 
and potential applications for in vivo imaging.  
 
8 
 
 
9 
 
 
 
Figure 2. Wavelength-dependent autofluorescence of vital organs and body 
fluids. (a) Image of the viscera of an athymic nude mouse taken immediately 
after sacrifice. The arrows indicate the location of gall bladder (GB), small 
intestine (SI) and bladder (Bl). Tissue autofluorescence was imaged using three 
different excitation/emission filter sets; (b) blue/green (460–500 nm/505–560 
nm); (c) green/red (525–555 nm/590–650 nm); and (d) Near-infrared (NIR) (725–
775 nm/790–830 nm). (Reprinted with permission from (Frangioni 2003), 
copyright 2003 Elsevier). 
 
 
 
(a) White light 
(b) Blue/green filter set 
(c) Green/red filter set 
(d) NIR filter set 
1 cm 
SI BI GB 
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Figure 3. Absorption coefficient (on a log scale) of oxygenated blood, 
deoxygenated blood, fatty tissue and water as a function of wavelength (Quek et. 
al. 2012). 
 
 
2.2 Labeling Mechanism of Fluorescent Probes 
Optical imaging has increasingly been used for dynamic noninvasive 
imaging of biological events in mouse models. Due to the lack of NIR 
fluorescence contrast generated by most tissues in the biological transparency 
window, exogenous fluorescent probes have to be administered for in vivo 
studies in order to visualize living tissues in its native physiological state. Ideally, 
the fluorescent probes to be administered should be biologically stable in the in 
vivo environment, and accumulate and produce imaging contrast at the target 
site. Fluorescent probes are classified according to their mechanism of contrast 
generation, collectively as non-specific, targeting and activatable (Figure 4) 
(Weissleder 2002).  
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Non-specific probes simply have differential distribution and are used to 
assess physiological processes such as changes in blood volume, permeability 
and perfusion in angiogenesis (Figure 4a). Typically, they achieve only low 
target-to-background signals due to the non-binding circulating probes producing 
significant background fluorescence within the compartment.  
Tissue- or cell-specific contrast is created by coupling a targeting moiety 
to a fluorescent probe that binds specifically to a receptor thus generating the 
readout signal (Figure 4b). These probes can report more detailed information 
about the biological events than non-specific probes. Targeting probes can 
achieve high target-to-background signals provided the targeting moiety has a 
high affinity for the receptor and any unbound probes are thoroughly removed 
from the system, thereby reducing the background fluorescence.  
Activatable probes comprise of donor-acceptor fluorophores that are 
coupled to each other in close proximity to maintain a quenched state (Figure 
4c). The fluorescence emission is activated by enzyme-mediated cleavage that 
releases the fluorescent probes. Activatable probes can attain high target-to-
background signals as these probes in their native injected state are relatively 
undetectable. 
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Figure 4. Modes of contrast generation of fluorescent probes. (a) Non-specific 
compartmental distribution of the probes. (b) Targeted binding of probes via 
surface ligands to molecular targets. (c) Activatable probes quenched in their 
native state and become fluorescent by enzyme-mediated cleavage. 
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2.3 Small Organic Fluorophores 
2.3.1 Non-Specific Organic-Dye Probes 
The choice of a suitable dye for in vivo imaging depends on many factors. 
The most important consideration would be the molar extinction coefficient and 
quantum yield of the dye in the NIR region (Gioux et al. 2010; Schaafsma et al. 
2011). Of all the dyes, cyanine makes up the majority of commercial fluorescent 
probes for in vivo applications. Cyanine is a synthetic dye family of the 
polymethine group with a conjugated chain of odd number of carbon atoms 
linked between two nitrogen centers (Figure 5) (Mishra et al. 2000). Among this 
class of compounds, carbocyanine dyes with indolic groups are readily available 
commercially and have also been synthesized in a large variety of analogues. 
The structure of carbocyanine is formed by reaction of two indolic isomers (either 
identical or different) linked on each end of a C1, C3 or C5 methine. The 
absorption and fluorescence emission wavelength is determined both by the 
chain length of the methine and the side chains attached to the indolic groups. 
Table 2 shows a series of commercially available carbocyanine dyes emitting in 
the visible to NIR range. These dyes generally exhibit high molar extinction 
coefficients but only have moderate fluorescence quantum yields up to 30 %. A 
prominent representative of the NIR cyanine dye is Indocyanine green (ICG). 
ICG was first synthesized in the fifties (Licha 2002) and is the only clinically 
approved dye available commercially. It has been used in optical imaging of 
changes in blood-brain barrier permeability after thrombus formation in a mouse 
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model of cerebral venous thrombosis (Kim et al. 2005) and liver perfusion in 
mouse (Liu et al. 2011). Clinically, ICG has been used in clinical retinal 
angiography (Herbort et al. 1998), hepatic function testing (Achilefu et al. 2002) 
and imaging of human brain (Liebert et al. 2006; Liebert et al. 2011). Since ICG 
binds tightly to plasma proteins and becomes confined to the vascular system, 
they are widely used for intraoperative assessment of vascular flow in 
cardiovascular surgery (Raabe et al. 2003; Taggart et al. 2003; Yamamoto et al. 
2011). Because of its amphophilicity and a shortage of functional groups 
available for conjugation, ICG could only function as a non-specific probe for in 
vivo imaging.  
 
Figure 5. Generalized structure of cyanine dyes. A and A' are two quaternized 
heteroaromatic bases. 
 
 
2.3.2 Targeting Organic-Dye Probes 
Covalent attachment of targeting moieties such as antibodies, antibody 
fragments, proteins and peptides to fluorescent dyes can significantly improve 
the target-to-background signal. The strategy of conjugating antibodies to 
cyanine dyes were first demonstrated by Folli et al. and Ballou et al. (Folli et al. 
1994; Ballou et al. 1995) and applied to fluorescence imaging of tumor in mice. 
Antibodies, however, have found limited utility due to their unfavorable 
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pharmacokinetics. The typical circulating half-life of antibodies is much shorter 
than the time required accessing a small tumor with reasonable accumulation, 
thus rendering effective targeting rare using antibodies (Ballou et al. 1997).  
To improve the pharmacokinetics of in vivo contrast agents, a possible approach 
is to reduce the conjugate molecular size while still preserving the targeting 
affinity of the labeled dyes. Neri et al. demonstrated this idea by conjugating 
antibody single chain fragments selected from phage display libraries against an 
angiogenesis-associated oncofetal fibronectin isoform to cyanine dyes and 
applied to imaging of angiogenesis in a variety of animal models (Neri et al. 
1997; Birchler et al. 1999). Alternative strategy is also shown in the work by 
Achilefu et al. and Licha et al. highlighting the successful application of receptor-
specific peptide-dye conjugates for fluorescent imaging of tumors (Becker et al. 
2001; Bugaj et al. 2001; Achilefu et al. 2002). As a whole, fluorescent dyes can 
be readily functionalized to achieve targeting. 
2.3.3 Activatable Organic-Dye Probes 
The concept of activatable NIR probes was introduced by Weissleder et 
al. for in vivo imaging of enzyme activity (Weissleder et al. 1999). Enzyme-
activatable probes contain either two identical or different fluorophores linked in 
close proximity to each other by a specific peptide linker. The fluorescence of the 
probes is essentially undetectable in the quenched state. After enzymatic 
cleavage, the fluorophores are separated to restore the fluorescence emission. A 
large number of activatable probes have been documented, among them the 
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enzyme activation of NIR targeting dyes is mediated mainly by tumor associated 
proteases, such as cathepsins, caspases and matrix metalloproteinases (Bremer 
et al. 2003; Weissleder et al. 2003; Figueiredo et al. 2006; Blum et al. 2007; 
Bullok et al. 2007; Edgington et al. 2009). The ability of activatable fluorescent 
probes to detect gene expression is particularly useful as a means to diagnose 
malignant molecular process in the early disease state (Marten et al. 2002). 
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Table 2. Structures and optical characteristics of commercial NIR cyanine dyes. 
Dye Structure 
Abs/E
m 
(Becker 
et al.) 
Molar 
extinction 
coefficien
t 
(M−1 cm−1) 
Quantu
m yield 
Indo-
Cyanine 
Green 
(ICG) 
(Schaafsm
a et al. 
2011)  
807/822 121,000 0.09 
Cy5.5 NHS 
ester 
 
675/694 250,000 0.23 
Cy7 NHS 
ester 
 
747/774 200,000 0.28 
Cy7.5 NHS 
ester§ 
 
788/808 223,000 N.A. 
 Information is obtained from supplier GE Healthcare website; 
§ 
Information is obtained from 
supplier Lumiprobe website. 
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2.4 Nanomaterial-Based Fluorescent Probes 
Despite the long history of in vivo optical imaging, organic dyes have 
suffered from small Stokes shifts, poor photostability, high plasma protein binding 
rate, aggregation and background fluorescence in aqueous medium (Escobedo 
et al. 2010). Attention has been increasingly channeled toward nanotechnology 
to search for new class of more effective probes. Many nanomaterials are 
already widely used as catalysts, and energy storage and electronic devices 
(Fischer et al. 1997; Lordi et al. 2001; Baughman et al. 2002; Huynh et al. 2002; 
Porti et al. 2003). Their application to the biomedical arena has attracted a 
similarly enthusiastic following. Interest in the nanomaterials arises from the fact 
that at nanoscale the properties of materials can be very different from their bulk 
counterparts. Firstly, nanomaterials when compared to the same mass of 
material existing in a larger form have a much higher surface area. As such, 
nanomaterials are more chemically reactive because of the high surface energy. 
In addition, at nanoscale range, quantum effects begin to dominate the behavior 
of matter, affecting the optical, electrical and magnetic behavior of materials 
(Buhro et al. 2003; Roduner 2006).  
Lately, the integration of nanotechnology with medicine has found many 
novel applications of nanomaterials. Nanoparticles can be engineered to 
overcome biological barriers for effective and targeted delivery of drugs, genes, 
and contrast agents (Bruchez et al. 1998). Active moieties such as proteins, 
peptides and nucleic acids can easily be conjugated to the surface of the 
nanoparticles for use as non-specific, targeting or activatable nanoprobes. The 
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following sections are devoted to the recent development of some particulate NIR 
fluorescent nanoprobes for potential in vivo imaging.  
2.4.1 Quantum Dots 
Fundamentally, quantum dots (QDs) are semiconductor nanocrystals that absorb 
photons of light and re-emit photons at a different wavelength (Figure 6a) 
(Michalet et al. 2005). Typically, QDs are of ~2–20 nm in diameter depending on 
the core composition and the surface coating or functionalization. Most of the 
QDs reported have a core/shell structure (Figure 6b) with the core composed of 
atoms from periodic groups II–VI (CdSe, CdTe, CdS, PbSe, ZnS and ZnSe), III–
V (GaAs, GaN, InP, InAs), and IV–VI (PbS). QDs differ from traditional organic 
fluorescent dyes and naturally fluorescent proteins in several important aspects. 
Firstly, QDs are extremely efficient in generating fluorescence, often by an order 
of magnitude higher than traditional fluorophores. In addition, QDs fluoresce 
without involving conjugated double-bond systems, thus exhibit greater 
photostability to enable long-term imaging without the concern of photo-induced 
deterioration. Another practical advantage of QDs is that their emission spectra 
are narrow and symmetric, thus minimizing any overlapping of colors in multi-
component imaging applications. With the same underlying material, varying the 
size of the QDs could give rise to different emission peaks, giving QDs 
unprecedented tunability. This enables the use of a single laser to excite and 
achieve multicolor emission for multiplexed assays (Bruchez et al. 1998; Chan et 
al. 2002; Alivisatos 2004; Medintz et al. 2005). These unique properties of QDs 
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have been increasingly exploited as bioimaging agents (Dubertret et al. 2002; 
Gao et al. 2004; Clarke et al. 2006; Li et al. 2010), theranostic platforms to 
deliver and track siRNA-based therapy (Derfus et al. 2007; Tan et al. 2007; Hong 
et al. 2010; Lee et al. 2010), nanosensors to study intracellular trafficking and 
unpacking of DNA nanocomplexes (Chen et al. 2006; Clapp et al. 2006; Ho et al. 
2006; Chen et al. 2008), and cell lineage-tracing agents to follow the 
development of stem and progenitor cells in vivo developmental (Rieger et al. 
2005; Slotkin et al. 2007).  
For in vivo imaging, the fluorescent emission wavelengths of the QDs 
ideally should be around 700–1000 nm, in the NIR region to minimize the 
endogenous fluorescence and the interference from major absorbers in the body. 
As presented in Figure 6a, CdTe (Zintchenko et al. 2009; Gaponik et al. 2010), 
CdTe/CdSe (Kim et al. 2004), CdHgTe/ZnS (Rogach et al. 2001; Tsay et al. 
2004), InAs (Zimmer et al. 2006), InAsxP1−x/InP/ZnSe (Kim et al. 2005), and 
PbSe (Dai et al. 2009; Jasieniak et al. 2011) are the possible QDs that emit in the 
NIR I region. All these QDs are usually passivated with a layer of ZnS or ZnSe to 
protect the core from oxidation and to prevent the leaching of toxic heavy metal 
ions such as Cd, Hg, As and Pb into the surrounding solution. However, with the 
several reports indicating Cd-containing QDs showing cytotoxicity under extreme 
conditions (Derfus et al. 2004; Kirchner et al. 2005; Hardman 2006; Cho et al. 
2007; Guo et al. 2007), there is a rising concern of using them for long term in 
vivo applications. Therefore, attention has been channeled to develop new class 
of quantum dots comprising of less-toxic elements. Some of these newly 
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developed NIR QDs include Cu-doped InP/ZnSe (Xie et al. 2009), CuInSe (Allen 
et al. 2008; Park et al. 2011), and CuInS2/ZnS (Pons et al. 2010; Koba et al. 
2011; Zhang et al. 2011). 
Among the synthetic routes of QDs, the most commonly used technique is 
to first generate the core by injecting liquid precursors into nonpolar coordinating 
organic solvent at a temperature as high as 300 °C and subsequently growing 
the shell layer of ZnS onto the core (Chan et al. 2002; Alivisatos et al. 2005; 
Michalet et al. 2005; Smith et al. 2006). QDs generated by this method are by 
default hydrophobic and are unsuitable for use in biological systems. To render 
them dispersible in aqueous medium, the QDs such as CuInS2/ZnS are 
transferred into aqueous phase either by ligand exchange with dihydrolipoic 
acid/polyethylene glycol 1000 (DHLAPEG100) or by encapsulation in 
phospholipid micelles (Dubertret et al. 2002; Uyeda et al. 2005; Carion et al. 
2007; Pons et al. 2010). The resulting water-soluble QDs emit at wavelength 
greater than 700 nm and could achieve good quantum yield of 30%. In vivo 
sentinel lymph node imaging with the CuInS2/ZnS QDs were performed in the 
work of Pons et al. by subcutaneous injection into regional lymph nodes (Thayer 
et al.) of healthy mice. It was observed that the QDs preferentially accumulated 
at the injection site, in the two regional LNs and to a lesser extent in other organs 
over a 10-day observation period (Pic et al. 2010). The results suggest that the 
LNs would be more sensitive toward acute QD toxicity. They further compared 
the inflammatory response of the two regional LNs treated with CuInS2/ZnS and 
CdTeSe/CdZnS QDs. Histological sections indicated inflammation only occurred 
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at 10 times dose concentration for cadmium-free QDs than for the Cd-containing 
counterparts (Figure 6c, d). This study highlights the advantage of cadmium-free 
QDs for safer NIR in vivo imaging. 
2.4.2 Colloidal Silicon Quantum Dots 
Silicon is one element that is most widely used in the microelectronics 
industry due to its outstanding performance as an electronic material (Melinon et 
al. 2007; Vogel 2007). Its inherit nontoxic and environmentally friendly 
characteristic has attracted much attention to develop silicon quantum dots (Si 
QDs) for biological applications (Erogbogbo et al. 2008; Fujioka et al. 2008; Park 
et al. 2009; Erogbogbo et al. 2010). An important step toward realizing these 
applications is the fabrication of colloidally and optically stable, water-dispersible 
Si QDs. Silicon QDs are typically prepared in a two-step process: first by CO2 
laser pyrolysis of silane to generate non-photoluminescent crystalline Si particles 
with an average diameter of 5 nm (Li et al. 2003). Etching with mixture of 
hydrofluoric acid and nitric acid is then followed to reduce the size and passivate 
the surface of the particles (Hua et al. 2006). Using this method Si QDs with size 
ranging from 1 to 5 nm and emission from blue to NIR can be obtained.  
In 2004, Li et al. first demonstrated the potential of Si QDs for biological 
applications. They grafted water-soluble polyacrylic acid Si QDs to label Chinese 
hamster ovary (CHO) cells for in vitro imaging (Li et al. 2004). In the recent work 
by Park et al. they delivered Si QDs loaded with anti-cancer drug doxorubicin D-
LPSiNPs into BALB/c mice and monitored both accumulation and degradation in 
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vivo (Figure 7) (Park et al. 2009). Si QDs are exhibiting the attractive attributes to 
be an effective and biocompatible nanomaterials system for theranostic purpose; 
they will undoubtedly see intense effort for further improvement and innovative 
applications. 
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Figure 6. (a) Emission maxima and sizes of quantum dots of different 
composition. (Reprinted with permission from (Michalet et al. 2005), copyright 
2005 Science). (b) Typical structure of a quantum dots (QD) for biomedical 
applications. The core of the QD is passivated by a second semiconductor 
material. The core/shell QD is made hydrophilic and biocompatible by a polymer 
coating. The surface of the QD is conjugated with a targeting ligand for specific 
recognition and interaction with biological molecules. (c) Histology sections of 
lymph node (Thayer et al.) 10 days post-injection: control regional auxiliary LN 
(RALN) (upper left), control right lateral thoracic LN (RLTLN) (lower left), RALN 
injected with QDs (upper right), and RLTLN injected with QDs (lower right). The 
lighter regions indicated with black arrows are the sites of inflammation. (d) 
Magnification of an inflammation area from RALN. There were many 
polynuclears observed but only some were indicated with blue arrows. 
Histiocytes (yellow arrows) and also vacuoles of digestion were also observed. 
(Reprinted with permission from (Pic et al. 2010), copyright 2009 Academy of 
Molecular Imaging). 
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Figure 7. (a) Representative fluorescence images of a mouse with an MDA-MB-
435 tumor. The mouse was imaged using a 615–665 nm excitation filter and an 
810–875 nm emission filter at the indicated time post-intravenous injection of D-
LPSiNPs (20 mg/kg). A strong signal from D-LPSiNPs is observed in the tumor, 
indicating significant passive accumulation in the tumor by the enhanced 
permeability and retention (Neri et al.) effect. (b) Ex vivo fluorescence images of 
the tumor from the mouse used in (a). (c) Fluorescence images of a tumor slice 
from the mouse in (a). Red and blue indicate D-LPSiNPs and cell nuclei (DAPI 
stain). (Reprinted with permission from (Park et al. 2009), copyright 2009 
Macmillan) 
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2.4.3 Gold Nanoclusters 
Fluorescence of noble metal nanoclusters (NCs) of gold and silver 
comprising of several to tens of atoms have drawn great attention in the past 
decade because of their remarkable optical properties (Zheng et al. 2007; 
Devadas et al. 2010; Wu et al. 2010; Guo et al. 2011; Selvam et al. 2011; Sun et 
al. 2011; Yuan et al. 2011). Because of their minuscule size, high chemical 
stability and biocompatibility, NCs are increasingly being exploited for sensing 
(Huang et al. 2009; Shang et al. 2009; Wei et al. 2010), biolabeling (Yu et al. 
2007; Richards et al. 2008) and bioimaging (Yu et al. 2009). Typically, the size of 
NCs is less than 2 nm and their properties are governed by their subnanometer 
dimensions. Their size regime is intermediate of atomic and nanoparticles in 
which they no longer have plasmon resonance and Mie’s theory is non-
applicable (Zheng et al. 2007). In fact, the size of noble metal NCs is comparable 
to the Fermi wavelength of the conduction electrons, leading to molecule-like 
features such as discrete size-dependent electronic transitions, fluorescence and 
charging properties.  
Multitudes of strategies have been developed for the synthesis of gold 
nanoclusters (AuNCs). One of which is chemical reduction of Au precursors in 
the presence of thiol stabilizers to afford AuNCs that fluoresce in the blue to 
near-IR regions (Negishi et al. 2004; Negishi et al. 2005; Wang et al. 2005; 
Negishi et al. 2007; Shichibu et al. 2007). However these NCs exhibit low 
quantum yields (QY) (0.001–0.1%). AuNCs can also be prepared via template-
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assisted synthesis within the cavities of dendrimers (Zheng et al. 2007) with 
greater than 10% QY at the expense of fairly long reaction time of ~2 days along 
with the production of large nanoparticles (NPs) as byproduct. Another commonly 
used technique to prepare AuNCs is by ligand-induced core etching of metal NPs 
to yield blue-emission NCs (Duan et al. 2007). Fine-tuning of the core etching 
method led Lin et al. to generate NIR AuNCs by first producing 6-nm diameter 
gold nanoparticles core stabilized with dihydrogenlipoic acid (DHLA) 
(AuNC@DHLA) (Jana et al. 2003; Lin et al. 2009). Conjugation of AuNC@DHLA 
with biomolecules can easily be achieved with the carboxyl group on DHLA via 
carbodiimide chemistry. Polyethylene glycol (PEG, 5 kDa), PEG-biotin and avidin 
have been attached in this manner. The shortcoming of these NCs is the low 
quantum yield of 1–3%. Nevertheless, the authors demonstrated the specific 
labeling capability of the AuNCs toward fixed human hepatoma cells (HepG2) 
and also the non-specific uptake of the AuNCs by human aortic endothelial cells. 
The results make obvious that these AuNCs are relatively nontoxic.  
  With increasing interest in applying NIR fluorescent probes for bioimaging, 
effort has been devoted to developing biocompatible AuNCs via aqueous 
synthetic routes with biological molecules (Bao et al. 2010). Xie et al. (Xie et al. 
2009) has developed an innovative method by exploiting the reducing capability 
of bovine serum albumin (BSA) to prepare AuNCs consisted of 25 gold atoms 
with red emission (Xie et al. 2009). The synthesis is similar to the 
biomineralization activities of organisms. Once added to aqueous BSA solution 
the Au ions were sequestered and entrapped within the protein molecules. The 
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reduction ability of BSA was activated when the pH of the reaction was adjusted 
to ~12 and the ions were progressive reduced to AuNCs in situ (Figure 8a). 
Additional reductant, such as NaBH4 would be required to yield AuNCs that emit 
at 683 nm. The quantum yield of the NIR AuNCs produced by this method was 
also low (0.1%). Despite that, Wu et al. demonstrated the applicability of these 
AuNCs for in vivo tumor fluorescence imaging using  
MSD-MB-45 and HeLa tumor xenograft models. They attributed the high 
accumulation of the NIR AuNCs in the tumor areas to the enhanced permeability 
and retention (Neri et al.) effects (Figure 8b) (Wu et al. 2010).  
2.5 Carbon Materials 
2.5.1 Single-Walled Carbon Nanotubes 
Carbon nanotubes (CNTs) represent another class of nanomaterials 
attract intense interest since their discovery in 1991 (Iijima 1991). CNTs are 
cylindrical tubes of sp2 carbon with superior optical, electrical, and mechanical 
properties, thus have wide range of potential applications as nanoelectronics 
devices and engineered composite materials (Fischer et al. 1997; Baughman et 
al. 2002). In addition, CNTs have been extensively explored as intracellular 
delivery vehicles for drugs, proteins and genes in cancer therapy (Feng et al. 
2011; Liu et al. 2011). 
CNTs are categorized as single-walled nanotubes (SWNTs) and multi-
walled nanotubes (MWNTs). So far, only SWNTs have been reported to possess 
high emission in the NIR II region, making them suitable for deep-tissue in vivo 
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imaging (Welsher et al. 2009). In general, SWNTs are most commonly 
synthesized by chemical vapor deposition that involves the heating of an alumina 
substrate with a layer of transition-metal catalytic nanoparticles, which serve as 
seeds to nucleate the growth of the nanotubes in a furnace with a stream of 
hydrocarbon gas flowing through the tube reactor (Dai 2002). SWNTs 
synthesized by this method have vast possibilities in the type of carbon tube 
molecules, giving rise to variation in band gaps ranging from ~10 meV to ~0.5 eV 
(Dai 2002). 
Welsher et al. suggested that the biggest obstacle in realizing the potential 
of SWNTs as NIR II probes is producing SWNTs with high quantum efficiency 
and good biocompatibility (Welsher et al. 2009). To overcome this issue, the 
authors came up with a strategy of first debundling and solubilizing the 
hydrophobic, pristine SWNTs in sodium cholate by sonification, followed by 
surfactant exchange to displace the sodium cholate with pegylated phospholipid 
(DSPE-mPEG). The resulting water-soluble SWNTs exhibit several emission 
peaks across the NIR II region when excited at 808 nm (Figure 9). When 
delivered into athymic nude mice via tail-vein injection, the systemic circulation 
and biodistribution of the SWNTs can be followed for over two minutes (Figure 9) 
(Welsher et al. 2011). This work shows the advantages of fluorescence imaging 
in the NIR II region and their potential impact in advancing nanomedicine.  
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Figure 8. (a) Schematic of the formation of AuNCs in BSA solution. (b) 
Fluorescence images of mice with a MDS-MB-45 tumor. Strong signal from 
AuNCs was observed in the tumor (red circle), indicating significant passive 
accumulation in the tumor by the EPR effect. White arrows indicate tumor site. 
(c) Ex vivo fluorescence image of the muscle and tumor tissue around the tumor 
from the mice used in b. (Reprinted with permission from (Wu et al. 2010), 
copyright 2010 The Royal Society of Chemistry). 
 
 
Figure 9. Left panel: Fluorescence spectrum of DSPE-mPEG functionalized 
SWNTs excited at 808 nm, showing several emission peaks in the NIR II ranging 
from 1000–1400 nm. Right panel: Frames from video imaging of mice injected 
with SWNTs. At 3.5 s (A and E) post tail-vein injection, the lungs are the 
dominant feature, corresponding to flow of oxygen-poor, SWNT-rich blood to the 
lungs. At 5.3 s (B and F), the SWNT-rich blood flows through the highly 
vascularized kidney followed by the liver at 17.3 s (C and G) and the spleen at 69 
s (D and H). (Reprinted with permission from (Welsher et al. 2011), copyright 
2011 PNAS).  
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2.6 Conclusion and Outlook 
The potential of NIR fluorescent nanoprobes for in vivo application is 
unlimited. The drawbacks of organic dyes such as poor photostability, undesired 
aggregation and fluorescence in aqueous solution can be resolved by innovative 
NIR nanoprobe designs. In particular the versatile, nanomaterials-based NIR 
fluorescent probes offer ample opportunity to optimize their optical and targeting 
properties. Among all nanomaterial-based fluorescent probes, Si QDs is the only 
system that can be directly loaded with drugs and biodegraded into silicic acid 
that can be excreted efficiently through renal clearance. Like other nanomaterial-
based fluorescent probes, improvement of their quantum efficiency, however, will 
still require significant effort. Robust and environmentally friendly synthetic routes 
that can produce these nanomaterials-based NIR nanoprobes with uniform size 
and colloidal stability represent other significant challenges. The widespread 
application of NIR fluorescent nanoprobes awaits demonstration of their long 
term biocompatibility, in vivo targeting efficacy as well as parallel development of 
advanced optical instrumentation for deep-tissue imaging capability. 
Nevertheless, their role in advancing the field of nanomedicine will undoubtedly 
be essential.  
 
 
 
32 
 
Chapter 3 
Synthesis and Characterizations of Water Soluble, 
Silver-Doped Zinc Selenide Quantum Dots 
 
3.1 Background 
 Nanomaterials are increasingly being used in the biomedical field because 
they have size comparable to biological molecules (Figure 10). They can 
effectively interact with biomolecules either on the surface of cells or within cells, 
thus can be used to interrogate molecular events. Nanomaterials can be 
engineered to incorporate multifunctionalities into a single platform thereby 
achieving simultaneous treatment and diagnosis. In particular, nanoparticles 
have been used in drug delivery for more than two decades owing to their stable 
and large payload delivery, multiplexing capacity, precise targeting capability, 
and tunable biodistribution profiles (Jokerst et al. 2011). Recently, they are 
gradually more popular for imaging purposes due to their unique way of 
interaction with electromagnetic waves (Wagner et al. 2006). Some of the newly 
developed nanoparticles for imaging include gold nanoclusters and colloidal 
silicon nanoparticles. The advantages of gold nanoclusters are its ultrasmall size 
(< 2 nm) and biocompatibility, but its quantum yield has yet to go beyond 0.1 %. 
Colloidal silicon nanoparticles are biocompatible and biodegrable with 
reasonable quantum yield of ~10.2 %. However, it is unsuitable for in vivo 
imaging due to that its absorption range falls in the visible range, a region where 
tissues and body fluids readily absorb and scatter photons and interferes with 
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signal collection and processing (Quek et. al. 2012). To date, the most studied 
nanoparticles for bioimaging is quantum dots (QDs), and the overall goal of this 
research is to explore new strategy to develop novel hydrophilic QDs for 
biomedical research applications. 
 
 
Figure 10. A comparison of the scales of biological entities and nanomaterials.  
(http://en.wikipedia.org/wiki/Nanoscopic_scale#mediaviewer/File:Biological_and_
technological_scales_compared-en.svg) 
 
Quantum dots (QDs) are widely exploited in the optoelectronic industries 
as superior nanomaterials for use as light emitting diode, data storage and 
quantum information processing (Jeon et al. 1991; Hong et al. 2001). Lately, as a 
result of the success in making water-soluble QDs along with the integration of 
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nanotechnology with biology and medicine, quantum dots have emerged as 
potential candidates for several important biological applications. 
Fundamentally, QDs are luminescent semiconductor nanocrystals that 
absorb photons of light and re-emit photons at a different wavelength QDs 
(Figure 11). Typically, QDs are of ~2-20 nm in diameter depending on the atoms 
it was made up of and the surface coating or functional groups added. Most of 
the QDs reported have a core/shell conjugate structure with core composed of 
atoms from periodic groups II-VI (CdSe, CdTe, CdS, PbSe, ZnS and ZnSe), III-V 
(GaSz, GaN, InP, InAs), and IV-VI (PbS). QDs have several important 
differences as compared to traditional organic fluorescent dyes and naturally 
fluorescent proteins. Firstly, QDs are extremely efficient for generating 
fluorescence which could often be many times higher than traditional fluorophore. 
In addition, QDs fluoresce without involving conjugated double-bond systems, 
thus exhibit greater photostability and enabling long-term imaging experiments to 
be carried out without the fear of any photo-induced deterioration. Another 
practical advantage of QDs is that, the emission from QDs is precise, narrow and 
symmetric, as so, the overlapping other colors is minimal. With the same 
underlying material, varying the size of the QDs could give rise to different 
emission peaks, giving QDs unprecedented tunability, thus enable the use of a 
single laser to excite to achieve multicolor emission and multiplexed assays to be 
achieved simultaneously (Chan et al. 1998; Bruchez et. al. 1998; Chan et. el. 
2002). With all these unique properties, QDs show promising biological 
applications as, bioimaging agents (Clarke et al. 2006), siRNA (Derfus et al. 
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2007), FRET (Clapp et al. 2006), cell lineage tracing agents (Rieger et al. 2005, 
Slotkin et. al. 2007).  
To date, QDs used in biological applications mostly contain cadmium as 
core material. They are synthesized via conventional technique involving the 
injection of precursors into reaction flasks containing boiling, nonpolar 
coordination organic solvents, such as trioctylphosphine (Marten et al. 2002), 
trioctylphosphine oxide, and hexadecylamine (Smith et al. 2006). At elevated 
temperature, the precursors decompose to form monomers that allow nucleation 
to occur and subsequently leading to the generation hydrophobic, nearly 
monodisperse nanocrystals with high fluorescence emission intensity. For 
biological applications, additional surface modification steps are required to 
render the solubility of the QDs in aqueous media which typically led to an 
alteration of optical properties of the nanocrystals.   
  Over the past decade several major advances have been achieved in 
development of QDs in aqueous environments due to increasing recognition of 
the potential of QDs for biomedical applications (Gaponik et al. 2010).  Thus far, 
ZnSe (Zheng et. al. 2007; Xing et. al. 2008), CdS, CdSe, CdTe (Zheng et al. 
2007), and HgTe (Rogach et al. 2001) have been successfully prepared in 
aqueous solution stabilized with thiol ligands. However, the issue of possible 
leakage of toxic heavy metal ions in vivo is at large a major concern that impedes 
the wide application of QDs. In this context, we proposed to develop an aqueous 
method to prepare heavy metal-free quantum dots intended for biological 
applications. We describe here the synthesis of silver-doped zinc selenide 
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quantum dots in water with L-glutathione as stabilizing ligand. The physical and 
optical characteristics of the as-synthesized QDs are also evaluated. 
   
Figure 11. Photos of a series of ZnCdSeS alloyed Quantum Dots with gradually 
stepping emission from violet to deep red.  
(http://www.plasmachem.com/shop/en/226-zncdses-alloyed-quantum-dots) 
 
3.2 Experimental Details 
3.2.1 Materials   
  Zinc acetate, copper (II) acetate, silver acetate, selenium powder (~100 
mesh), L-glutathione reduced, citric acid trisodium salt, DL-cysteine, and sodium 
borohydride were purchased from Sigma-Aldrich (St. Louis, MO, USA). Gold (III) 
acetate was acquired from Alfa Aesar. Solvents used for synthesis and 
spectroscopic measurements were purchased from J. T. Baker and EMD 
Chemicals. All chemicals were used without further purification. 
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3.2.2 Spectroscopic and Microscopic Measurements 
Ultraviolet-visible spectra were measured by a double monochromator 
Shimadzu UV2501PC spectrophotometer equipped with a 50W halogen lamp 
and a D
2 
lamp and using a 1.0 cm path length quartz cell. Spectra were 
presented in terms of λ
max 
in nm, the wavelength of the absorption peak, and 
absorbance, A, as defined by the following equation:  
 
 
where I
0 
is the intensity of the radiant energy striking the sample, and I is the 
intensity of the radiation emerging from the sample.  
A more convenient expression of absorption intensity is that derived from the 
Lambert-Beer law as described:  
 
 
where ε = molar absorptivity of the sample,  
c = concentration of solute expressed in moles per litre,  
l = path length through the sample. 
 
Fluorescence spectra were measured on Cary Eclipse Fluorescence 
Spectrophotometer equipped with a xenon flash lamp excited at 420 nm and 5 
nm bandpass. The fluorescence quantum yield (x) is given by the ratio of 
photons absorbed to photons emitted through fluorescence. In order to determine 
the quantum yield, QD515 was dissolved in 0.1 M sodium acetate buffer (pH 5.2) 
while QD625 and QD710 were dissolved in phosphate buffered saline (PBS) in a 
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series of concentrations. The uv-vis absorbance readings were recorded using a 
10 mm fluorescence cuvette. Absorbance readings of QD515 were taken at 420 
nm, QD625 and QD710 were monitored at 540 nm. The emission spectra of 
QD515 excited at 420 nm, QD625 and QD710 excited at 540 nm were recorded 
on the spectrofluorometer to generate a plot of integrated fluorescence intensity 
vs absorbance with intercept at 0.  For this study, fluorescein dissolved in 0.1 M 
NaOH was used as know standard for evaluation of QD515, rhodamine 101 in 
0.01 % HCl/ethanol was used for QD625 and QD710 testing. The quantum yield 
was calculated based on the equation: 
 
 
 
 
where the subscripts ST and X denote standard and test respectively, Ф is the 
fluorescence quantum yield, Grad the gradient from the plot of integrated 
fluorescence intensity vs absorbance, and  the refractive index of the solvent. 
The X-ray diffraction pattern was collected on a XDIF1 X-Ray 
Diffractometer Philips X’Pert PRO MRD HR X-Ray Diffraction System with a Cu 
X-ray source operated at 40 kV and 20 mA. Nanocrystal powders were smeared 
onto silicon wafers for analysis. 
The particle size of the water-soluble silver-doped ZnSe nanocrystals 
were characterized using transmission electron microscopy (TEM, FEI Tecnai G² 
Twin). Samples for TEM were prepared by putting a drop of suspension on 
carbon/formvar coated, 300-mesh copper grid.   
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Zeta potential measurement was recorded on a Malvern Nano ZS 
Zetasizer. 
3.2.3 Synthesis of Silver-Doped Zinc Selenide Quantum Dots 
On the whole, all reactions were performed under argon gas. Sodium 
hydroselenide (NaHSe) was freshly prepared based on a previous method 
(Klayman et al. 1973) and was swiftly added to a reaction flask containing a 
mixture of zinc acetate (1 M, ZnOAc2) and silver acetate (0.01 M, AgOAc) with L-
glutathione (GSH) as stabilizer. The pH values of the reactions were adjusted to 
with 10 M NaOH. The molar ratio of ZnOAc2:Se: GSH used in the experiments 
was kept at 8:1:15-21 while ZnOAc2:AgOAc was at 50-100:1. The reactions were 
performed at room temperature. The final emission of the QDs was controlled by 
varying the growth time and pH. After the reaction, 2-propanol was added to the 
QDs until turbidity occurred; the nanocrystals were isolated by centrifugation and 
washing of the product was repeated another two times. The pelletized 
nanocrystals was dissolved in Millipore water and purified by ultrafiltration with 3 
K MWCO membrane. The purified product was freeze dried and stored under 
argon atmosphere at 4 C. 
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3.3 Results and Discussion 
3.3.1 Synthesis of water soluble, sliver-doped ZnSe (ZnSeAg) QDs 
A series of ligand (cysteine, citric acid sodium salt, and L-glutathione) was 
tested to determine if stabilized ZnSe QDs could be obtained. The reaction was 
performed at reflux temperature and the results are summarized in Appendix A. 
The results clearly indicated that thiol functional group has an important role in 
the synthesis. During the reaction the thiol proton will cleave and bind to the 
surface of the QDs thereby stabilizing the products. Citric acid sodium salt does 
not contain thiol functional group thus no QDs could be formed from the reaction. 
However, with cysteine as stabilizer, the QDs formed eventually precipitated at 
the end of reaction due to aggregation. We have identified that GSH is the 
appropriate stabilizer for the subsequent reactions.  
We next screened through the acetate salt of copper, silver and gold to 
verify which dopant has the capability to tune the emission into the near-infrared 
range. Our results in Appendix B indicate that using copper (II) acetate as 
dopant, we could only tune the emission to 438 nm, which is non ideal for 
bioimaging. We did not obtain any QDs with gold (III) acetate as dopant probably 
due to both ZnSe and gold nanoparticles were formed at the same time and 
bound to each other, leading to quenching of the fluorescent signal of the 
products. With silver acetate as dopant, the as-synthesized QDs could be tuned 
to have near-infrared emission. However, to achieve controllable growth rates, 
the reactions with silver acetate as dopant have to be performed at room 
temperature.  
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QDs have attracted significant attention for several important biomedical 
applications. While most QDs were prepared through organometallic synthetic 
route, there is a rising interest to develop aqueous-based synthesis involving 
milder reagents along with biomolecules. Glutathione (GSH) is a tripeptide 
comprising a carboxylate and amino groups in a single molecule. GSH exists in 
most organisms and has widely being used for detoxification of heavy metals 
(Singhal et al. 1987). In our design, we have selected to use L-GSH as the 
stabilizing ligands to allow us to further introduce bioactive moieties that would 
recognize specific biological structure. The synthesis of silver-doped QDs was 
based on the reaction of zinc acetate and sodium hydroselenide. Since the 
emission of ZnSe is located in the ultraviolet range, metal impurities are often 
added as dopant into ZnSe nanocrystals to alter the emission range (Erwin et al. 
2005; Norris et al. 2008). In the synthesis we have incorporated silver acetate 
that resulted in a red shift in the emission peaks that is in agreement with the 
report by Mocatta, et. al. (Mocatta et al. 2011). The influence of parameters, such 
as concentrations of precursors and pH of reaction were systematically 
investigated and the results are summarized in Appendix C-H.  
The schematic for the synthesis is as depicted in Figure 12. The growth of 
the ZnSeAg nanocrystals in aqueous solution was controlled by the Ostwald 
ripening process, whereby monomers released by the dissolution of smaller 
particles are consumed by the larger particles. Some studies on cadmium-based 
nanocrystals have shown that at lower pH, Cd2+-thiol complexes tightly on the 
surface of the nanocrystals thus inhibiting the growth (Swayambunathan et al. 
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1990; Gao et al. 1998). Similarly in our system, when the pH of the reaction 
decreased from 7 to 5, the growth rate of the nanocrystals decreased remarkably 
(Figure 13).   
3.3.2 Physical characterizations of QDs 
Figure 14a shows an image of the ZnSeAg QDs under the illumination of a 
365 nm ultraviolet light, the corresponding absorption and emission spectra are 
depicted in Figure 14b. Representative compositions are presented in Table 3; 
under optimal conditions, the as-synthesized GSH-capped ZnSeAg QDs with 
broad absorption (up to ~ 700 nm) and emission ranging from 515-710 nm could 
be synthesized within 15-160 min. 
TEM analysis of sample QD710 indicated the diameter of the QDs is ~2-8 
nm (Figure 15a). At such a low feed dopant concentration, it was not possible to 
distinguish the metal regions in the micrograph, indicating that the Ag atoms are 
dispersed in the nanocrystals. Further evidence is shown in the x-ray diffraction 
(Figure 15b) where no fingerprints of Ag domain. The XRD result indicated that 
the as-synthesized nanocrystals belonged to the cubic zinc blende structure. The 
peak positions of ZnSeAg were located between positions for pure cubic ZnSe 
and pure cubic ZnS. This result suggested that the surface Zn2+-GSH layer might 
have slightly decomposed, leading to the incorporation of sulfur into the 
nanocrystals (Li et al. 2005).  In addition, some broadening of the peaks is 
observed that can be due to a small degree of structural disorder in the 
naocrystals. Zeta potential analysis (Figure 15c) showed that QD710 has an 
average -35.9 mV. We account this observation to ionization of the two carboxyl 
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group on GSH at pH 5 and presented an overall negative surface charge on the 
QDs. 
From EDX analysis (Figure 16 and Table 4), we conclude that with we can 
use as low as 0.03 mol % of silver dopant to tune the emission of the QDs to 710 
nm. Figure 17 and 18 are plots of fluorescence intensities vs absorbance of 
fluorescein, QD510, rhodamine 101, QD625 and QD710 respectively. The 
gradients of the plots were obtained to evaluate the quantum yield of the silver-
doped ZnSe samples. The quantum yield of QD515, QD625 and QD710 are 
found to be 20-47 % and is summarized in Table 5.   
 
 
 
Figure 12. Synthesis of ZnSeAg QDs via green chemistry route. 
 
 
Table 3. Representative synthesis compositions for obtaining quantum dots with 
emission as indicated in table. 
Sample Emax  
(nm) 
Zn(OAc)2 
(mmol) 
AgOAc 
(mmol) 
GSH 
(mmol) 
NaHSe 
(mmol) pH 
Reaction 
time 
(min) 
QD515 515* 0.1 0.001 0.122 0.012 8 15 
QD625 625 0.1 0.001 0.252 0.012 5 15 
QD710 710 0.1 0.001 0.122 0.012 7 160 
* Disperse the QDs in water or PBS and allow the Ag+ to leach out (~ 4 weeks). 
 
R
T 
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Figure 13. Growth rate as a function of the emission peak for ZnSeAg at different 
pH.  
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Figure 14. (a) Photographs of QD510, QD625 and QD710. (b) Absorption 
spectra (dotted lines) and fluorescence spectra (solid lines) of ZnSeAg QDs with 
three different colors. 
 
 QD515       QD625        QD710 (a) 
(b) 
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Figure 15.  (a) TEM image of QD710. (b) Powder x-ray diffraction of QD710 
indicated a zinc blende crystal structure, insert is a zinc blende unit cell 
(http://upload.wikimedia.org/wikipedia/commons/e/e8/Zinc-selenide-unit-cell-3D-
balls.png). (c) Zeta potential analysis of QD710.  
 
 
 
 
 
 
 
 
 
(a) 
(b) 
(c) 
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Table 4. Elemental composition of QD710 from EDX 
Mole Ratio Zn Se S Ag 
Feed Ratio 2.5 1 2.5 0.10 
Observed Ratio 2.27 1 2.39 0.03 
 
 
 
 
Figure 16. Energy-dispersive x-ray (EDX) analysis of QD710. 
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Figure 17. Plots of fluorescence intensities vs absorbance of fluorescein and 
QD510.  
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Figure 18. Plots of fluorescence intensities vs absorbance of rhodamine 101, 
QD625 and QD710. 
 
 
 
Table 5. Quantum Yield (Ф) of silver-doped ZnSe samples 
Sample QY (%) 
QD515 35.0 
QD625 47.4 
QD710 20.9 
PBS = 1.333, ethanol = 1.361 and NaOH = 1.3576 (Weber 2003). 
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3.4 Conclusion 
 
In summary, we have developed an aqueous strategy to synthesize water-
soluble, near-infrared emitting, silver-doped ZnSe QDs stabilized by a 
biomolecule, L-glutathione. Their emission ranged from 515 to 710 nm with 20-47 
% QY. Compared to conventional synthetic methods, our approach is mild, 
inexpensive and environmentally friendly. We believe our strategy will be an 
alternative for preparing biocompatible QDs for wide range of biological 
applications. 
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Chapter 4 
Biological Evaluation of Water-Soluble, Silver-Doped 
Zinc Selenide Quantum Dots 
 
4.1 Background 
Engineered nanomaterials are envisaged to have many exciting impacts in 
biomedical research], but progress is impeded by a lack of understanding of how 
these materials interact with biological environments. Among all the 
nanomaterials, quantum dots (Nabiev et al.) are most widely studied.  A prime 
issue related to QDs is their toxicity. For any newly designed QDs it is crucial that 
these nanomaterials would not have any adverse effects upon interaction with 
the cells. However, not all nanomaterials are inherently benign.  Studies have 
shown nanomaterials do affect biological systems at cellular, subcellular and 
protein levels (Colvin 2004; Donaldson et. al. 2001). To assess their utility in 
biological systems it is important to scrutinize the behavior of QDs both at in vitro 
and in vivo.  
Though in vitro studies require less stringent toxicological characterization 
than in vivo, however, in vitro experiments have less ethical issues, less 
expensive to run, are easier to control and reproduce and could provide 
preliminary ideas how a material will respond in the body. Many in vitro studies 
have suggested that nanomaterials could induce toxic reaction, triggering 
nanomaterials to degrade, thus releasing toxic metals (Kirchner et al. 2005; 
Hardman et. al. 2006) and producing reactive oxygen species (Lovric et al. 
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2005). In addition, surface chemistry of nanomaterials has been shown to affect 
toxicity in vitro (Lovric et al. 2005).  
However, due to the fact that different cell types have different responses 
to nanomaterials, different intracellular fates are likely to affect the toxicity study 
outcomes. Furthermore, most toxicity data derived from in vitro studies might not 
truly reflect complexity arising from in vivo environments. For instance, diversity 
in the toxicity results is seen in the evaluation of carbon nanotubes (CNTs). 
Study by Manna et. al. (Manna et al. 2005) have found CNTs exhibits toxicity in 
vitro, while in vivo findings by Schipper et. al. (Schipper et al. 2008) did not 
display significant toxicity. Likewise, toxicology results for fullerenes by Sayes et. 
al. (Sayes et al. 2007) indicated the outcomes from in vivo evaluation were very 
different from in vitro data. Hence, it is preferred to include in vivo study for 
toxicological evaluation of a novel nanomaterial.   
The objective of this study is to evaluate the toxicity of our novel heavy-
metal free, near-infrared emitting QDs with in vitro protocol. After establishing 
preliminary find for in vitro study we will continue to conduct in vivo testing to 
understand the biodistribution of the QDs in mice. These in vitro and in vivo 
assessments could provide meaningfully evaluation of the potential safety of our 
novel QDs for biological applications.    
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4.2 Experimental Details 
 
4.2.1 Materials 
Minimum essential medium- (MEM-), Dulbecco’s Modified Eagle 
Medium (DMEM), penicillin/streptomycin, and L-glutamine were purchased from 
Life Technologies (Rockville, MD). Fetal bovine serum was supplied by Atlanta 
Biologicals. Polyethylenimine, branched (Mw ~25 K) (PEI), hematoxylin and eosin 
y were obtained from Sigma-Aldrich (St. Louis, MO), Citrosol and Cytoseal were 
from Fisher Scientific and Thermo Scientific respectively.  
4.2.2 Human mesenchymal stem cell (hMSCs) maintenance 
 
Bone marrow-derived hMSCs provided by Tulane University Health 
Sciences Center were cultured MEM- supplemented with 20% FBS, 1% 
penicillin/streptomycin, and 1 % L-glutamine. The cells were maintained at 37 C, 
5 % CO2 environment. Subculture was performed at 1:5 to avoid exceeding 85 % 
cell confluence. hMSCs used in the experiments were between passages 6-9. 
 
4.2.3 Murine macrophage cell line (RAW 264.7) maintenance 
RAW 264.7 cells (ATCC, Manassas, VA) were cultured in DMEM 
supplemented with 10% FBS, 1% penicillin/streptomycin, and 2 mM L-glutamine. 
Subculture was performed at 1:5 to avoid exceeding 85 % cell confluence. RAW 
264.7 used in the experiments were between passages 9-12. 
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4.2.4 QDs treatment for hMSC and RAW 264.7 
hMSC and RAW 264.7 were separately seeded in 96 well plates (20,000 
cells/well) in 100 L MEM- and DMEM respectively. After 24 h of incubation, the 
medium was refreshed with 100 L of medium containing the silver-doped ZnSe 
and polyethlenimine (PEI) (Sigma, 25 kD) at various concentrations. Cells were 
incubated for 24 h before cell viability assays were performed. 
 
4.2.5 MTS cell viability assay 
 
Cellular viability of the quantum dots were determined by [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] (MTS) assay (Promega, Fitchburg WI) in comparison with 
PEI. Following 24 h of incubation with the silver-doped ZnSe nanocrystals and 
PEI, medium was removed from the wells and replaced with 100 L of fresh 
culture medium. 20 L of MTS stock solution was added to each well and the 
plate was subsequently incubated at 37 C for 2 h before taking the absorbance 
on a microplate reader (BMG Labtech Fluostar Optima, Durham, NC) at 490 nm. 
Controls were cells that were incubated with culture medium.  
4.2.6. In vivo and ex vivo imaging 
The biodistribution of QD710 in live animals and collected tissues were 
visualized a Perkin Elmer IVIS Spectrum in vivo imaging system. The QDs was 
excited at 675 nm and its emission detected using 820 nm filter. 
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4.2.7 In vivo biodistribution analysis 
 
Animal use protocols were reviewed and approved by the Institutional 
Animal Care and Use Committee of Duke University. 4 weeks old male nude 
mice were purchased Charles River Laboratories and allowed to acclimate to the 
animal facility for at least 48 h. Thereafter, the animals were placed on adjusted 
vitamins diet (Harlan Laboratories, Madison, WI) 1 week prior to experimentation 
to eliminate fluorescent material usually found in standard rodent chow. For in 
vivo imaging, mice were anesthetized with isoflurane (2 % in oxygen) delivered 
from a precision vaporizer.  QD710 was dissolved in PBS at a concentration of 
50 mg/mL, Qdot800 ITK Amino (PEG) (Life Technologies) was diluted to 0.16 M 
with PBS. Typical volumes injected were 50 or 100 L for footpad and 
intravenous injection respectively. After each study, anesthetized mice were 
euthanized and major organs were collected for ex vivo imaging and histology 
analysis.  
 
4.2.8 Hematoxylin and eosin (H&E) staining of frozen sections 
Frozen sections were first fixed in 10 % buffered formaldehyde for 20 min 
and washed in water for 5 min. The sections were then immersed in hematoxylin 
solution (Sigma-Aldrich, St. Louis, MO) to stain the nuclei for 1 min, washed in 
water for 5 min, and briefly immersed in 95 % ethanol. Staining of cytoplasms 
were carried out by immersing in eosin for 2 min and dipped once quickly in 
water. Dehydrations were performed next by immersing the sections in 95 % 
ethanol for 1 min, and then three times in 100 % ethanol for 10 dips each. The 
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sections were washed three times in Citrosol for 2 min each. Lastly, the slides 
were mounted with Cytoseal and sealed with #1.5 coverslip. 
 
 4.2.9 Microscopic analysis 
 
 After 24 h of incubation with QD710, medium was removed from the wells 
and the cells were washed three times with warm PBS and viewed under a 
fluorescent microscope excited at ex = 485 nm with em = 650 nm captured by a 
CCD camera (CoolSnap HQ, Roper Scientific). 
 Confocal images were taken on a Zeiss LSM 510 inverted confocal 
microscope with a 40x/1.3 oil lens. For Hoescht 33426 staining, 405 nm diode 
laser was used for excitation and DAPI emission filter for signal readout. For 
QD710 binding assessment, 561 nm diode laser was used as excitation source 
and Red emission filter to capture the signal.   
 H & E stained samples were visualized on Zeiss Axio Imager widefield 
fluorescence microscope equipped with QImaging MicroPublisher 5.0 MP colour 
camera and 20x/0.50 DIC lens. 
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4.3 Results and Discussion 
4.3.1 Toxicity assay and microscopic analysis 
MTS is a colorimetric method for determination of number of viable cells in 
proliferation. MTS is bioreduced by viable cells to formazan product (Figure 19) 
that is soluble culture medium (Barltrop et al. 1991). Metabolically active cells 
contain dehydrogenase enzymes that convert MTS into aqueous, soluble 
formazan. Absorbance at 490 nm corresponds to quantity of formazan produced 
and is directly proportional to number of viable cells in culture.  
 
Figure 19. Structures of MTS tetrazolium salt and its formazan product. 
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In the toxicity study, QDs with different emission were evaluated in two 
different cell lines. Branched PEI, a commonly used polymeric carrier for 
transfection of plasmid DNA into target cells, was included as control. PEI has 
shown cytotoxicity in a range of cell lines. The cytotoxicity arises from two 
different mechanisms: (1) the disruption of the cell membrane leading to 
necrosis; (2) the disruption of the mitochondrial membrane post-internalization 
leading to apoptosis (Hunter 2006). As shown in Figure 20, at higher 
concentration of 100 g/mL there was a slight drop in the viability in the RAW 
264.7 cells treated with QDs. On contrary, minimal change of viability in hMSC 
(Figure 21) was observed. The insensitivity of hMSC towards the treatment of 
QDs could possibly be attributed to the high serum contents in the medium 
provide buffering effect towards toxicants (Gartlon et al. 2006). In addition, 
slightly higher viability was observed in hMSC treated with QD510 across the 
concentration range. This could possibly be due the stimulation of the cells in the 
presence of QD510 (Thayer et al. 2005). 
Microscopic analysis of RAW 264.7 cells and hMSC are shown in (Figure 22) 
and (Figure 23) respectively. The results indicated that QD710 readily bind 
nonspecifically with both RAW 264.7 cells and hMSC. In addition, regardless of 
the cells type, when treated with the negatively charged QD710, the QDs could 
escape from endosomes, release in the cytoplasm and accumulate near the 
nuclear pore complexes. This observation is in agreement to the results by 
Nabiev et. al. (Nabiev et al. 2007) 
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Figure 20. MTS cell viability of RAW 264.7 cells following 24 h of incubation with 
QD515, QD625, QD710 and PEI. Values are the mean ± standard error of the 
data (N = 8). 
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Figure 21. MTS cell viability of hMSC following 24 h of incubation with QD515, 
QD625, QD710 and PEI. Values are the mean ± standard error of the data (N = 
8). 
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Figure 22. Fluorescent and confocal microscopy imaging of RAW 264.7 cells. (a) 
Brightfield image. (b) Fluorescent image with ex = 485 nm, em = 650 nm (c) 
Brightfield image. (d) Image with 561 nm excitation source and observed with red 
filter. (e) Nuclei staining with Hoescht 33346, excitation at 405 nm and observed 
with DAPI filter. (f) Overlap of two images.  
(a) (b) 
(c) (d) 
(e) (f) 
62 
 
 
 
 
Figure 23. Fluorescent and confocal microscopy imaging of hMSC. (a) Brightfield 
image. (b) Fluorescent image with ex = 485 nm, em = 650 nm (c) Brightfield 
image. (d) Image with 561 nm excitation source and observed with red filter. (e) 
Nuclei staining with Hoescht 33346, excitation at 405 nm and observed with 
DAPI filter. (f) Overlap of two images.  
 
 
 
 
 
 
(a) (b) 
(c) (d) 
(e) (f) 
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4.3.2 In vivo biodistribution 
Imaging in small animals is a challenge due to absorbance and scattering, 
and autofluorescence in tissues. This can be overcome when imaging is done in 
the near-infrared region where absorbance and scattering is minimal (Lim et al. 
2003; Frangioni et. al. 2003). In addition, Bawendi and Frangioni have 
demonstrated selective sentinel lymph nodes mapping with subdermally 
administered NIR QDs in rodent and pig models in which QD fluorescence was 
observable up to 1 cm deep through the skin of the animals (Kim et al. 2004; Kim 
et al. 2005).  
We have developed a procedure for the synthesis of water-soluble, near-
infrared emitting, silver-doped ZnSe QDs with diameters < 8 nm. We were able to 
tune the final peak emission wavelength to 710 nm (QD710) that is ideal for in 
vivo applications. We were able to conduct in vivo biodistribution studies along 
with commercial QD800-NH2 that we acquired from Life Technologies. The QDs 
were administered into the footpads of nude mice. The difference in migration of 
the two types of QDS was observed immediately. In the case of QD800-NH2, 
migration into the lymphatic system and staining of the popiteal lymph node 
required ~40 min after injection. In contrast, instead of entering the lymphatic 
vessels, we saw QD710 enter the systemic circulation and accumulate in the 
stomach of the mouse ~5 h after injection (Figure 24).  This observation is in 
agreement with the report by Nune et. al. which suggested that particles < 10 nm, 
when administered subcutaneously, will be absorbed by the capillary network 
that eventually got drained into systemic circulation (Nune et al. 2011). The 
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signal of QD710 in stomach increased after 24 h probably due to the slowness in 
the migration in the systemic circulation. Interestingly, the signal of QD710 in the 
stomach was detectable up to at least 7 days. When the QDs were administered 
to the tail vein, QD800-NH2 QDs was found to traverse through the lymphatic 
vessels and accumulated at the linguinal lymph nodes 5 h-24 h post treatment 
(Figure 25). The observations for QD800-NH2 are in agreement with results by 
Soltesz, et. al.  that particles larger than 10 nm will enter lymphatic system and 
become sequestered in the lymph node (Soltesz et al. 2006). However, for the 
case of QD710, we saw the QDs were accumulated in the stomach. The size of 
QD710 is < 8 nm, as so it probably could not efficiently filter by the kidney or 
concentrated in the bladder since the threshold for renal filtration is < 6m (Dellian 
et al. 2000). Since Zn2+ has a major role in regulating acidity in the secretory 
compartments of gastric gland, this could possibly account for the preferred 
accumulation of QD710 circulated near the stomach region (Liu et al. 2011).   
4.3.3 Histology analysis 
 
Histological assessment of the tissues was conducted to identify the 
existence of QDs in the samples and to determine whether tissue damage or 
inflammation occur. Directly after cryo-section, tissues were evaluated by 
confocal microscopy to search for QD710. A total of 50 sections were evaluated 
and only slices with fluorescent signals are shown in Figure 26 and Appendix I. 
Presented in Figure 26a is a confocal image of a cryo-section of the gastric 
mucosa that was found to contain QD710, and its representative histology result 
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is shown in Figure 26c. Overall, there were no apparent histopathological 
abnormalities to stomach of the treated mouse. QD710 was found in the whole 
section and not limited to specific section.  
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Figure 24. In vivo imaging of Ag-doped ZnSe QDs (ZSA710) and Qdot 800 ITK 
amino (PEG) quantum dots (Invitrogen) (QD800-NH2) after footpad injections in 
Nu/Nu mice. The mice were anesthetized, injected with PBS (50 L) as control, 
ZSA710 (50 L, 50 mg/mL) or QD800-NH2 (50 L, 0.16 M) and the fluorescence 
was measured with the IVIS Spectrum using filter sets 675/820 (Ex/Em). The 
fluorescence pattern was analyzed at different time interval post-injection, (a) 5 
hr, (b) 1 day, and (c) 7 days. The mice were sacrificed; the organs were 
harvested and imaged. (i) Kidneys, (ii) liver, (iii) spleen, (iv) intestines, (v) 
popiteal lymph nodes, and (vi) stomach. Fluorescence signals were observable 
up to 7 days post treatment for both type of QDs. QD800-NH2 QDs traversed 
through the lymphatic vessels and accumulated at the popiteal lymph nodes (LN) 
5 h-7 days post treatment. In contrast, ZSA710 QDs were circulated through 
systemic route post-injection and accumulated in the stomach for as long as 7 
days. At least three animals were treated with PBS, ZSA710 or QD800-NH2 for 
each condition. 
(a) 
(b) (c) 
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Figure 25. In vivo imaging of Ag-doped ZnSe QDs (ZSA710) and Qdot 800 ITK 
amino (PEG) quantum dots (Invitrogen) (QD800-NH2) after tail vein injection in 
Nu/Nu mice. The mice were anesthetized, injected with PBS (50 L) as control, 
ZSA710 (50 L, 50 mg/mL) or QD800-NH2 (50 L, 0.16 M) and the fluorescence 
was measured with the IVIS Spectrum using filter sets 675/820 (Ex/Em). The 
fluorescence pattern was analyzed at different time interval post-injection, (a) 0 
hr, (b) 5 hr, and (c) 1 day. QD800-NH2 QDs traversed through the lymphatic 
vessels and accumulated at the linguinal lymph nodes 5 h-24 h post treatment. In 
contrast, ZSA710 QDs were circulated through systemic route post-injection and 
accumulated in the stomach.   
 
 
 
 
 
 
 
 
 
 
(a) 
(b) 
(c) 
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Figure 26. Histology for a cryo-section of gastric mucosa. (a) Confocal image 
with 561 nm excitation source and observed with red filter. (b) Overlaps of 
brightfield and red filter. (C) Hematoxylin and eosin staining.  
 
 
 
 
 
 
 
 
 
 
Mucosa 
Smooth 
muscle cell 
(c) 
(a) (b) 
69 
 
4.4 Conclusion 
 
We have successful developed a series of water-soluble, silver-doped 
ZnSe QDs with emission in the near-infrared range. These QDs exhibited 
minimal toxicity to RAW 264.7 cells and hMSC. When tested in animal QD710 
was found to behave differently from conventional QDs. The underlying 
mechanism of QDs accumulating in the stomach is still unknown and further 
studies are required to address this observation. Overall, we have shown that 
silver-doped ZnSe QDs has the potential for biological applications. 
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Chapter 5 
Biofunctional Quantum Dots for Cell-Specific Targeting 
 
5.1 Background 
Gastric cancer is the second leading cancer-related death in the world 
(Zhang et al. 2012). Typically, early stages of gastric cancer do not show any 
symptom, and patients diagnosed with gastric cancer are already in advanced-
stage with a poor prognosis. When early gastric cancer is left untreated, it will 
progressively become gastric carcinoma that metastasizes aggressively; and 
along with the high resilience of the gastric cancer cells, this is attributed to the 
very poor survival rates of gastric cancer patients. The overall 5-year relative 
survival rate of all people with gastric cancer in the United States is about 28% 
(Tan et al. 2011). However, it has been shown that gastric cancer can be cured if 
it is diagnosed at an early stage (Tan et al. 2012).  
Functionalized quantum dots (QDs) are of great potential for biomedical 
research. With unique optical properties including broad absorption, spectra 
narrow emission spectra, high resistance to photobleaching and high 
photostability, QDs are excellent for candidates for cell-labeling studies. Since 
QDs has a large surface area, they can be readily modified to incorporate 
bioactive moieties. For cancer cell targeting studies, QDs are typically antibodies, 
ligands or peptides. In general, antibodies are most commonly used targeting 
moieties due to its high availability and specificity.   
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CD44 is a major cell surface receptor for hyaluronate, and is implicated in 
several cellular mechanism such as cell-cell interactions, cell adhesion and 
migration. Recently study has shown that some CD44 variants are associated 
with malignant transformation (Tao et al. 2011).  Particularly, CD44v6 isoform is 
overexpressed in the process of malignant transformation of gastric mucosa. The 
objective of this study is to take the advantage of the functional groups on L-
glutathione capped QDs to append bioactive moiety, thus producing QDs for cell-
specific targeting applications. Active targeting will be augmented by a primary 
monoclonal Mouse anti-Human CD44v6 antibody on QDs to bind with the 
receptors on human gastric adenocarcinoma cell line (AGS).Human small 
intestine cells (FHs 74 Int) was used as control for the cellular study. The 
targeting specificity and cellular internalization of the antibody-labeled QDs will 
be visualized by confocal microscopy.  
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5.2 Experimental details 
 
5.2.1 Materials 
CD44v6 Mouse Monoclonal Antibody (clone MA54), DMEM, Ham's F-12K 
(Kaighn's) Medium, penicillin/streptomycin, Hoescht 33342 were obtained from 
Life Technologies (Rockville, MD). Fetal bovine serum was supplied by Atlanta 
Biologicals. Polyethylenimine, branched (Mw ~25 K) (PEI), sodium meta-
periodate, epithelial growth factor (EGF) were purchased from Sigma Aldrich (St 
Louis, MO).  Sodium cyanoborohydride (NaCNBH3), and Zeba spin desalting 
column were supplied by Pierce Biotechnology (Rockford, IL).  
5.2.2 Preparation of CD44v6-QDs conjugate 
CD44v6-QDs was prepared by first activation of monoclonal mouse 
CD44v6 antibody.  10 L of sodium meta-periodate (0.2 M) in sodium acetate 
buffer (0.1 M) was added to 200 L of CD44v6 (0.5 mg/mL) in an amber bottle 
and incubated at room temperature for 50 min. The reaction mixture was purified 
through a Zeba spin column. The collected filtrate was added to a bottle 
containing 50 mg of QD710 in 2 mL of PBS and 10 L of 5 M NaCNBH3 that was 
pre-dissolved in 1 M NaOH. The reaction was allowed to proceed overnight at 4 
C. The reaction was purified by ultrafiltration with 100 K MWCO membrane, 
added with PBS to a final volume of 200 L and stored at -20 C. Absorption and 
fluorescence spectra of CD44v6-QDs in PBS were obtained with Shimadzu 
UV2501PC spectrophotometer and Cary Eclipse Fluorescence 
Spectrophotometer equipped with a xenon flash lamp excited at 450 nm and 5 
nm bandpass respectively. 
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5.2.3 Human gastric adenocarcinoma cell line (AGS) maintenance 
AGS was acquired from ATCC (Manassas, VA) Center were cultured in 
DMEM supplemented with 10% FBS, 1% penicillin/streptomycin. Subculture was 
performed at 1:5 to avoid exceeding 85 % cell confluence. AGS used in the 
experiments were between passages 49-52. 
5.2.4. Human small intestine cell line (FHs 74 Int) maintenance 
FHs 74 Int was acquired from ATCC (Manassas, VA) Center were 
cultured in Ham's F-12K (Kaighn's) medium supplemented with 10% FBS, 1% 
penicillin/streptomycin, and 30 ng/mL of EGF. Subculture was performed at 1:5 
to avoid exceeding 85 % cell confluence. FHs 74 Int used in the experiments 
were between passages 6-8. 
5.2.5 MTS cell viability assay 
Cellular viability of the quantum dots were determined by [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] (MTS) assay (Promega, Fitchburg WI) in comparison with 
PEI. Following 24 h of incubation with the silver-doped ZnSe nanocrystals and 
PEI, medium was removed from the wells and replaced with 100 L of fresh 
culture medium. 20 L of MTS stock solution was added to each well and the 
plate was subsequently incubated at 37 C for 2 h before taking the absorbance 
on a microplate reader (BMG Labtech Fluostar Optima, Durham, NC) at 490 nm. 
Controls were cells that were incubated with culture medium.  
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5.2.6 Immunofluorescent imaging 
AGS and FHs 74 Int were separately seeded with 10,000 cells/well in 8-
well Nunc™ Lab-Tek™ chambered coverglass (Fisher Scientific) in 400 L 
DMEM and Ham’s F-12K respectively. After 24 h of incubation, the culture media 
removed and the cells were washed three times with PBS (5 min per wash). The 
cells were fixed with 4 % paraformaldehyde for 15 min, followed by three 
washes, 5 min each with PBS. The cells were then blocked in 10 % FBS for 30 
min followed by three washes with PBS.  Subsequently, 200 L each of QD710 
(100 g/mL) and CD44v6-QDs (diluted to 1:200) in PBS were added in the wells. 
After 2 h of incubation at 37 C, the cells were subjected to nuclear staining with 
Hoescht 33342 (2 ug/mL) for 5 min and washed three times with PBS (5 min 
each). In a separate experiment, cells were directly incubated with 200 L of 
QD710 (100 g/mL) in culture media. After 2 h of incubation, the culture media 
removed and the cells were washed three times with PBS (5 min per wash). The 
cells were staining with Hoescht 33342 (2 ug/mL) for 5 min and washed three 
times with PBS (5 min each). The cells were visualized with a Zeiss LSM 510 
inverted confocal microscope with a 40x/1.3 oil lens.  A 405 nm diode laser for 
excitation and DAPI emission filter were used for Hoescht 33426 signals, and a 
561 nm diode laser and red emission filter were used for QDs readout. 
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5.3 Results and Discussion 
 
5.3.1 Preparation of CD44v6-QDs conjugate 
 
The reaction scheme of CD44v6-QDs conjugation is depicted in Figure 27. 
Aldehyde activation route was chosen over the conventional 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide (NHS) 
conjugated antibodies to QD so as to ensure that the antigen-binding domains 
will not be adversely affected. Activation of the activate the polysaccharides 
located in the Fc region of the Ab was achieved using a mild oxidant, sodium 
meta-periodate, to create two aldehyde groups that are spontaneously reactive to 
amine- and hydrazine-containing reagents. In the current conjugation, the 
generated aldehydes coupled with primary amines on L-glutathione to form Schiff 
bases intermediates that were in equilibrium with their free forms. Reductive 
amination was carried out with the addition of sodium cyanoborohydride to 
complete the reduction of the labile Schiff base intermediate to form a chemically 
stable, secondary amine linkage between CD44v6 and QD710. The absorption 
and fluorescence spectra of CD44v6-QDs are illustrated in Figure 28. The 
measurement revealed that CD44v6-QDs maintained the desired optical 
properties. Since the size of antibody and QDs are similar (Figure 10), the 
conjugation reaction possibly results in several CD44v6 antibodies reside on the 
surface of QDs as depicted in Figure 27. The optical properties of QDs are size-
dependent; a shift in emission peak could be due to the increase in overall size of 
the conjugate as compared to the primary QD710.  
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Figure 28. Absorption (···) and fluorescence (—) spectra of QD710 and CD44v6-
QDs. 
 
 
5.3.2 Cytotoxicity assay 
 
To evaluate the cytotoxic effects of our water soluble, silver-doped ZnSe 
QDs, the viability of AGS and FHs 74 Int cells were determined using a standard 
MTS assay. AGS and FHs 74 Int cells were incubated with QD515, QD625, 
QD710 and PEI at different concentrations for 24 h. As shown in Figures 29 and 
30, cells treated with QDs did not exhibit any significant drop in viability over the 
range of concentrations. Interestingly, the viabilities of AGS treated with QD625 
over the concentration range of 1-50 g/mL were slightly higher than the other 
two QDs. This could possibly be attributed to the stimulation effect of the cells in 
the presence of QD510 (Gartlon et al. 2006).  
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5.3.3 Immunofluorescent Imaging 
 
The immunofluorescent imaging were conducted with three different 
conditions: (1) direct treatment of non-fixed cells with QD710; (2) fixed cells 
without bovine serum blocking were incubated with QD710; (3) fixed cells 
subjected to bovine serum blocking were incubated with CD44v6-QDs. Figure 31 
and 32 are images of cells directly treated with QD710. Without fixation and 
blocking, nonspecific binding was observed. In a passive uptake study by Nabiev 
et. al. (Nabiev et al. 2007), they have shown that negatively charged thiolglycolic 
acid-capped CdTe QDs could escape from endosomes, release in the cytoplasm 
and associate near nuclear pore complexes (NPC). Our results agree with those 
reported by Nabiev et. al., in that the negatively charged QD710 was seen in the 
NPC of AGS and FHs 74 Int. As a result of blocking with bovine serum 
nonspecific binding of the QDs can be eliminated to avoid false-positive results 
(Figure 33 and 34). The most superior property of the CD44v6-QDs is the precise 
recognition of the receptors on AGS cell. Due to this specificity, we achieved cell-
specific binding of AGS cells as shown in Figure 35. Our study clearly validated 
that in the absence of the receptors, CD44v6-QDs will not bind with FHs 74 Int 
cells (Figure 36).  
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Figure 29. MTS cell viability of AGS following 24 h of incubation with QD515, 
QD625, QD710 and PEI. Values are the mean ± standard error of the data (N = 
8). 
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Figure 30. MTS cell viability of FHs 74 Int following 24 h of incubation with 
QD515, QD625, QD710 and PEI. Values are the mean ± standard error of the 
data (N = 8). 
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Figure 31. Confocal microscopy imaging of AGS cells. Cells were directly treated 
with QD710 for 2 h at 37 C. (a) Brightfield image. (b) Image with 561 nm 
excitation source and observed with red filter. (c) Nuclei staining with Hoescht 
33346, excitation at 405 nm and observed with DAPI filter. (d) Overlap of two 
images.  
 
 
 
(a) (b) 
(d) (c) 
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Figure 32. Confocal microscopy imaging of FHs 74 Int cells. Cells were directly 
treated with QD710 for 2 h at 37 C. (a) Brightfield image. (b) Image with 561 nm 
excitation source and observed with red filter. (c) Nuclei staining with Hoescht 
33346, excitation at 405 nm and observed with DAPI filter. (d) Overlap of two 
images.  
(a) (b) 
(c) (d) 
83 
 
 
 
Figure 33. Confocal microscopy imaging of AGS cells. Cells were fixed and 
blocked with bovine serum prior to incubation with QD710 for 2 h at 37 C. (a) 
Brightfield image. (b) Image with 561 nm excitation source and observed with red 
filter. (c) Nuclei staining with Hoescht 33346, excitation at 405 nm and observed 
with DAPI filter. (d) Overlap of two images.  
 
 
 
(a) (b) 
(c) (d) 
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Figure 34.  Confocal microscopy imaging of FHs 74 Int cells. Cells were fixed 
and blocked with bovine serum prior to incubation with QD710 for 2 h at 37 C. 
(a) Brightfield image. (b) Image with 561 nm excitation source and observed with 
red filter. (c) Nuclei staining with Hoescht 33346, excitation at 405 nm and 
observed with DAPI filter. (d) Overlap of two images.  
 
 
(a) (b) 
(c) (d) 
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Figure 35. Confocal microscopy imaging of AGS cells. Cells were fixed and 
blocked with bovine serum prior to incubation with CD44v6-QDs for 2 h at 37 C. 
(a) Brightfield image. (b) Image with 561 nm excitation source and observed with 
red filter. (c) Nuclei staining with Hoescht 33346, excitation at 405 nm and 
observed with DAPI filter. (d) Overlap of two images.  
 
 
 
 
(a) (b) 
(c) (d) 
86 
 
 
 
Figure 36.  Confocal microscopy imaging of FHs 74 Int cells. Cells were fixed 
and blocked with bovine serum prior to incubation with CD44v6-QDs for 2 h at 37 
C. (a) Brightfield image. (b) Image with 561 nm excitation source and observed 
with red filter. (c) Nuclei staining with Hoescht 33346, excitation at 405 nm and 
observed with DAPI filter. (d) Overlap of two images.  
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
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5.4 Conclusion 
 
We have tested the series of water soluble, silver-doped ZnSe QDs, stabilized 
with L-glutathione and showed that they have minimal toxicity towards AGS and 
FHs 74 Int cells. We have demonstrated the feasibility of chemical modification 
on the surface with L-glutathione capped QDs to incorporate bioactive moiety for 
cell-specific targeting purposes. The available carboxylate and amine groups on 
L-glutathione could be used for conjugation with various bioactive moieties and 
thus this series of QDs could potentially be used for a wide range of specific 
targeting applications. 
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Chapter 6 
Near-Infrared Emitting, Silver-Doped Zinc Selenide 
Quantum Dots As Nanoprobe For Delivery To Draining 
Lymph Nodes 
 
6.1 Background 
 
In any drug discovery and development, the challenge to translate from 
preclinical to clinical phases depends on the efficacy and safety of the drug. A 
more effective way to screen for drugs to move into clinical phases is to conduct 
preclinical animal testing to provide reliable insight into potential efficiency and 
indication of safety for use in humans (Contag 2002). As so, the ability to conduct 
real-time in vivo analysis of molecular events, assessment of therapeutic efficacy 
of test compound will definitely be a valuable technique for any drug 
development. 
In vivo fluorescent imaging is a relatively safe imaging modality as it 
utilizes, nonionizing light as excitation source. In vivo fluorescent imaging is 
especially challenging due to fluorescent signal attenuation varies according to 
the emission wavelength, type and depth of tissues (Frangioni 2003). Tissues 
tend to absorb and scatter photons and generate strong autofluorescence when 
illuminated with light source in the range of 450-600 nm but are biologically 
transparent in the NIR range (650-950 nm). Most fluorescent proteins have 
emission peaks in the visible spectrum, several organic dyes emitting in the NIR 
are being developed as alternative imaging reagents to conjugate to 
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biomolecules. However, organic dyes are susceptible to photobleaching, and 
aggregation in aqueous media (Quek et. al. 2012). As such, it is justifiable that 
with its improved photostability, quantum dots are increasingly being used for 
labeling and in vivo imaging. The objective of this study is to explore the 
feasibility of using our near-infrared emitting, silver-doped ZnSe QDs as a 
nanoprobe to elucidate the delivery of encapsulated cytokine to the draining 
lymph nodes.  
Draining lymph nodes (DLN) are dynamic lymphoid structures where B, T 
and other immunity cells could be found. They act as filters or traps for foreign 
particles and maintain the proper functioning of immunity (Soderberg et al. 2005; 
McLachlan et. al. 2003). During infection, mast cells release stable heparin-
based particles containing tumor necrosis factor (Kunder et al. 2009; Abraham et 
al. 2010; St John et al. 2012) that are delivered to the DLN. However, how these 
molecules could remain intact during the delivery process is pending to be 
addressed. Here we demonstrate the labeling of heparin with silver-doped ZnSe 
QDs, use it as a nanoprobe to form nanocomplexes chitosan, a biopolymeric 
cation, and track the delivery of encapsulated recombinant tumor necrosis factor 
to popiteal lymph nodes.  
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6.2 Experimental Details 
6.2.1 Materials 
Gold (IIII) chloride trihydrate (HAuCl43H2O), citric acid trisodium salt 
(Na3C6H5O7), sodium sulfite were obtained from Sigma-Aldrich(St Louis, MO). 
Dibromodecane and thiourea were bought from Alfa Aesar. 1-Ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-
hydroxysulfosuccinimide (NHS); 2-(N-morpholino)ethanesulfonic acid (MES) 
buffer were from Pierce Biotechnology (Rockford, IL). Chitosan of Mw ~470 K 
was purchased from Novamatrix and heparin of Mw ~15 K was from EMD 
Millipore. Recombinant tumor necrosis factor alpha (TNF-) was acquired from R 
& D Systems 
6.2.2 Synthesis of 10-mercaptodecanesulfonate sodium salt (MDS)  
10-Bromodecanesulfonic acid sodium salt 
The synthesis of MDS was performed with slight modification from a 
method reported by Fiurasek, et. al. (Fiurasek et al. 2007). Dibromodecane 
(85.44 g, 0.284 mol) was added to a round bottom flask containing 120 mL of 
ethanol and 40 mL of water, and the mixture was heated to reflux with continuous 
stirring. Sodium sulfite (7.13 g, 0.057 mol) dissolved in 80 mL of water was 
gradually introduced into the reaction flask with a dropping funnel over a period 
of 3 hours to facilitate the reaction on only one end of the dibromodecane. After 
an additional 4 hours of refluxing, the reaction flask was cooled to allow excess 
dibromodecane to separate from the reaction mixture. The aqueous layer was 
washed three times with 50 mL of petroleum ether to remove any trace of 
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unreacted dibromodecane. The purified aqueous layer was concentrated on a 
rotary evaporator to remove ethanol. The remaining solution was cooled at 4 C 
to allow 10-bromodecanesulfonic acid sodium salt to crystallize. The resultant 
crystals were isolated by filtration and vacuum dried overnight. The dried product 
was verified by proton NMR. 
10-S-thiouronium decanesulfonate 
10-bromodecanesulfonic acid sodium salt (11.51 g, mol) and thiourea 
(2.71 g, 0.036 mol) were dissolved in a mixture of 125 mL of ethanol and 40 mL 
of water. After 6 hours of refluxed with stirring, ethanol was removed by rotary 
evaporation. The resulting solution was allowed to cool at 4 C for crystallization 
of the product to occur. The dried product was verified by proton NMR.  
10-mercaptodecanesulfonate sodium salt 
10-S-thiouronium decanesulfonate (6.31 g, mol) was dissolved in 72 mL of 
2 M sodium hydroxide and the reaction flask was refluxed under argon gas for 3 
hours to bring about base hydrolysis to cleave the C-S bond thus releasing 
alkylthiol and urea. The reaction flask was removed from heating and kept under 
argon atmosphere and allowed to cool to room temperature. Concentrated 
sulfuric acid was slowly added to the reaction mixture to adjust the pH of the 
solution to 7 in order to facilitate protonation of the thiol functional group. The 
solution was then cooled in ice for crystallization to take place. The purified 
product was dried under vacuum and evaluated by NMR.   
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6.2.3 Gold nanoparticle synthesis 
 
Gold nanoparticle was prepared according to the method reported by 
(Turkevich et al. 1951, Frens, 1973 #8). 0.1534 g of HAuCl43H2O was dissolved 
in 15.34 mL of Millipore water to make up 1 wt % stock solution. 0.2052 g of 
Na3C6H5O7 was added to 20.52 mL of water to make 1 wt % sodium citrate stock 
solution. 10 mL of sodium citrate was added to a flask containing 4 mL of gold 
stock solution and 400 mL of boiling water under reflux. After 10 min the reaction 
flask was removed from heating and allowed to cool to room temperature. The 
gold nanoparticle was filtered with 0.45 m cellulose acetate membrane and kept 
at 4 C for long term storage. 
6.2.4 Functionalization of gold nanoparticle 
50 mg of 10-mercaptodecanesulfonate sodium salt was sonicated in 5 mL 
of a 50:50 ethanol/water mixture and added to 25 mL of gold nanoparticle 
solution. The functionalization was allowed to proceed at room temperature for 3 
days. Unbound thiol ligand was removed in the supernatant fraction after 
centrifugation at 15,000 rpm for 20 min. The gold nanoparticles were redispersed 
in Millipore water and the washing was repeated twice.  
6.2.5 Labeling of chitosan with Alexa Fluor 790 
 
4 mL of 0.5 wt % chitosan (0.5 wt % in 0.1 M NaAc) and 50 uL AF790 in 
DMSO were placed in an amber sample vial and allowed to react with stirring at 
room temperature for 3 h. Thereafter, the product was purified by ultrafiltration 
with a 100 K MWCO membrane. The product was washed twice with water 
followed by freeze drying. The final product was validated on 1H-NMR and 
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spectrofluorometer. The dried polymer was stored at -20 C for long term 
storage. 
6.2.6 Conjugation of QDs to Heparin 
 
0.0262 g EDC, 0.0390 g NHS, 0.2 g of heparin were allowed to react in 
MES buffer for 20 min. The mixture was then purified in Zeba desalting spin 
column to remove any excess reagents. The collected filtrate was added to a vial 
containing 0.4 g of QD710 in PBS. The reaction proceeded at room temperature 
for 2 h. The product was purified by ultrafiltration with a 10 K MWCO membrane, 
washed twice with water and freeze-dried. The final product was examined on a  
spectrofluorometer. The purified product was kept at 4 C prior to use.  
6.2.7 Layer-by-layer depositon on gold nanoparticle  
 
TNF- (10 g/mL), chitosan (0.5 wt % in 0.1 M sodium acetate buffer) and 
heparin (1 wt % in water) were used as stock solutions for deposition. 5 L of 
TNF- was added to 1 mL of thiol-funtctionalized gold nanoparticles suspended 
in 10 mM NaCl. After 20 h adsorption, excess TNF-- in supernatant of 
centrifugation was removed. The nanocomplexes were redispersed in water and 
washing process repeated twice. 10 mM NaCl was then added to the 
nanocomplexes and the adsorption process was with the addition of 100 L 
chitosan solution, followed by heparin, chitosan, and so on until a total of eight 
depositions were achieved. Each of the deposition steps was evaluated on the 
uv-visible spectrophotometer, zetasizer, and TEM.  
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6.2.8 WEHI 164 clone 13 fibrosarcoma cell line (WEHI-13VAR) 
maintenance 
WEHI-13VAR was acquired from ATCC (Manassas, VA) were cultured in 
RPMI-1640 supplemented with 10% FBS, 1% penicillin/streptomycin. Subculture 
was performed at 1:5 to avoid exceeding 85 % cell confluence. AGS used in the 
experiments were between passages 6-8. 
6.2.9 MTS cell viability assay 
Cellular viability of the quantum dots were determined by [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] (MTS) assay (Promega, Fitchburg WI).  WEHI-13VAR was 
seeded in 96-well plate at 20,000 cells per well and incubated overnight. On the 
day of testing, nanocomplexes containing rTNF- were dispersed in RPMI-1640 
containing 25 mM HEPES, 3 % FBS, and 0.5 g/mL actinomycin (Sigma-Aldrich) 
were loaded into each well. After 20 h of incubation, culture media were removed 
from the wells and replaced with 100 L of fresh culture medium. 20 L of MTS 
stock solution was added to each well and the plate was subsequently incubated 
at 37 C for 2 h before taking the absorbance on a microplate reader (BMG 
Labtech Fluostar Optima, Durham, NC) at 490 nm. Controls were cells that were 
incubated with culture medium.  
6.2.10 Nanocomplexes characterization 
 
Ultraviolet-visible spectra were measured by a double monochromator Shimadzu 
UV2501PC spectrophotometer equipped with a 50W halogen lamp and a D
2 
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lamp and using a 1.0 cm path length quartz cell. Zeta potential measurement 
was recorded on a Malvern Nano ZS Zetasizer. The size of the nanocomplexs 
were characterized using transmission electron microscope (TEM, FEI Tecnai G² 
Twin). Samples for TEM were prepared by putting a drop of suspension on 
carbon/formvar coated, 300-mesh copper grid.   
 
6.2.11 Animal study 
 
Animal use protocols were reviewed and approved by the Institutional 
Animal Care and Use Committee of Duke University. 4 weeks old female nude 
mice were purchased Charles River Laboratories and allowed to acclimate to the 
animal facility for at least 48 h. Thereafter, the animals were placed on adjusted 
vitamins diet (Harlan Laboratories, Madison, WI) 1 week prior to experimentation 
to eliminate fluorescent material usually found in standard rodent chow. For in 
vivo imaging, mice were anesthetized with isoflurane (2 % in oxygen) delivered 
from a precision vaporizer.  1 mL of nanocomplexes were concentrated by 
centrifugation and dispersed in 50 L PBS. 20 L of the nanocomplexes were 
administered in footpad. After each study, anesthetized mice were euthanized 
and the popiteal lymph nodes were collected for ex vivo imaging.   
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6.3 Results and Discussion 
 
6.3.1 Synthesis of 10-mercaptodecanesulfonate sodium salt. 
The reaction scheme for synthesis of 10-mercaptodecanesulfonate 
sodium salt is shown in Figure 37. In the first step of the reaction, the compound 
was verified by 1H-NMR (Figure 38) and was confirmed to be 10-
bromodecanesulfonic acid sodium salt (Yield = 11.51 g). The product from 
second step reaction was validated on 1H-NMR (Figure 39) and was shown to be 
10-S-thiouronium decanesulfonate (Yield = 6.32 g). The 1H-NMR of the product 
from final step is depicted in Figure 40 and verified as 10-
mercaptodecanesulfonate sodium salt (Yield = 5.83 g).  
 
97 
 
 
Figure 37. Reaction scheme for synthesis of 10-mercaptodecanesulfonate 
sodium salt. 
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Figure 38. 1H-NMR of 10-bromodecanesulfonic acid sodium salt. 
 
 
99 
 
 
Figure 39. 1H-NMR of 10-S-thiouronium decanesulfonate. 
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Figure 40. 1H-NMR of 10-mercaptodecanesulfonate sodium salt.  
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6.3.2 Labeling of chitosan with Alexa Fluor 790 
 
The reaction scheme for the conjugation of AlexaFluo 790 to chitosan is 
depicted in Figure 41. The exact chemical structure of AF790 is undisclosed by 
supplier; the only information provided is that it contains a succinimidyl ester 
readily react with primary amine group to form stable amide linkage. Figure 42 is 
1H-NMR of chitosan, which showed the peaks between 1-4.5 ppm corresponding 
to the proton on the sugar rings of chitosan. A close examination of the 1H-NMR 
of AlexaFluo 790 (Figure 43) indicated that the dye contains several aromatic 
proton clearly in the range of 6.5-9 ppm. From the 1H-NMR of chitosan-AlexaFluo 
790 (Figure 44), we could find some peaks appearing in 6.5-9 ppm, clearly 
showing the inclusion of AlexaFluo 790 in chitosan. The absorbance and 
fluorescent spectra of AlexaFluo 790 and chitosan-AlexaFluo 790 are shown in 
Figure 45 and 46 respectively. There was no significant shift in the emission peak 
in the chitosan-AlexaFluo 790 sample, indicating there was no aggregation of the 
dye that would result in the quenching of the fluorescent signal.  
 
102 
 
 
Figure 41. Schematic of comjugation of Alexa Fluor dye to chitosan via 
succinimidyl ester linkage to amine functional group.  
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Figure 42. 1H-NMR of chitosan.  
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Figure 43. 1H-NMR of AlexaFluo790.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aliphatic protons 
Protons on aromatic rings 
D2O d-DMSO 
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Figure 44. 1H-NMR of chitosan-AlexaFluo790.  
D2O D-acetic acid 
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Figure 45. Absorption (···) and fluorescence (—) spectra of AlexaFluo 790 (ex = 
710 nm). 
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Figure 46. Absorption (···) and fluorescence (—) spectra of chitosan-AlexaFluo 
790 (ex = 710 nm). 
 
 
 
6.3.3 Conjugation of QD710 to heparin  
 
Conjugation of QD710 to heparin was perform via via two-step 
carbodiimide crosslinking procedures. (EDC) first activated carboxyl group on 
heparin to form an amine-reactive O-acylisourea intermediate. Since the reaction 
was performed at a pH of 5.5 in 2-(N-morpholino)ethanesulfonic acid (MES) 
buffer, the intermediate will be susceptible to hydrolysis, making it unstable and 
short-lived in aqueous solution (Staros et al. 1986). To improve the efficiency of 
the EDC coupling reaction, NHS was incorporated to react with the amine-
reactive intermediate to form an amine-reactive-NHS ester. Thereafter, QD710 
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was introduced into the reaction to allow the amine functional group on 
glutathione to react to form the stable amide linkage between QD710 and 
heparin (Figure 47). The fluorescence spectrum of heparin was shown in Figure 
48. Since the length of heparin is ~ 9 nm (Murugesan et al. 2008), multiple 
heparin molecules could possibly attached to the surface of QDs. The observed 
shift in the emission spectrum might be the result of several heparin molecules 
conjugated to QDs thus leading to an increase in the overall size of the QDs.    
 
 
Figure 47. Schematic of conjugation of quantum dots to heparin via a two-step 
carbodiimide reaction. 
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Figure 48. Absorption (···) and fluorescence (—) spectra of QD710-Heparin.  
 
 
6.3.4 Layer-by-layer depositon on gold nanoparticle (Au NP)  
 
 The creation and design of nanocarriers for drug delivery are of great 
interest because of their possible clinical applications. With optimized 
formulation, therapeutic nanocarriers could effectively deliver cargos to targeted 
cells and tissues, potentially reducing side effects and drug dose to achieve 
therapeutic benefits. One method of preparation of encapsulated nanocarriers is 
by random self-assembled aggregates of polyelectrolytes with therapeutic 
agents, resulting in large particles of heterogenous sizes (> 100 nm) (Neu et al. 
2005; Pozharski et al. 2007). For lymphatic delivery purposes the ideal particle 
size is 10-80 nm, particles > 100 nm will remain largely at the injection site (Nune 
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et al. 2011). Alternative method that could circumvent the limitations of previous 
system is a layer-by-layer (LbL) approach that makes use of monodisperse gold 
nanoparticles (Au NPs) as template for assembly and delivery of cargos.   
LbL sequential deposition of oppositely charged polyelectrolytes is a well-
established technique for thin films formation on flat surfaces and microparticles 
(Gittins et al. 2001). Its application to nanoparticles of diameter < 100 nm is 
limited because of issues such as aggregation arising from the crosslinking of the 
particles by the polyelectrolyte chains and removal of unbound polyelectrolytes 
from the coating (Mayya et al. 2003; Schneider et al. 2008).  
We present here a simple approach to optimizing the experimental 
parameters for depositions of TNF- and with QD-labeled polyanions on 20 nm 
Au NPs for in vivo delivery to the draining lymph nodes. The schematic for layer-
by-layer deposition on gold nanoparticles is depicted in Figure 49 (Elbakry et al. 
2009). Direct complexation on citrate-stabilized Au NPs was unstable due to that 
the citrate ions are only physical bound to the surface of Au and the polymer will 
eventually desorbed from the Au NPs surface. In order to successfully introduce 
coating on Au, a thiol ligand has to be used to replace the citrate ion to form 
stable chemical bond with Au. At the same time, the free end on the thiol group 
must contain ionic functionality for interaction with polyelectrolytes. 10-
mercaptodecanesulfonic acid sodium salt (MDS) was used for the ligand 
exchange step. After the ligand exchange, polyelectrolytes of opposite charge 
were introduced and so on. We first investigated the optimized conditions for the 
coating by studying the effect of the concentration of MDS (Figure 50). 
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Absorbance spectra were collected as an indication to the change of the coated 
surface. The plasmonic absorption peaks are summarized in Table 6. From this 
experiment we found that 10 mg of MDS added to 1 mL of Au NPs would cause 
2 nm shift in the band peak, higher MDS will cause larger shift. Subsequent 
coating Au NPs with MDS was kept at 10 mg/mL. 
  
 
 
Figure 49. Schematic of layer-by-layer coating on Au nanoparticles. 
 
 
Next, we continued to explore the concentration of salt that will cause minimal 
aggregation in the system. Figure 51 is the absorbance spectra and Table 7 is 
the summary of the Plasmon band peak of Au in various NaCl concentration. 
From the results we found that 10 mM of NaCl would be ideal to avoid inducing 
aggregation of the Au NPs. In our study, we have included zeta potential 
measurement as indicators to polyelectrolyes interaction. A reversal of the zeta 
potential after completion of each coating signified the deposition of each 
polyelectrolyte. The zeta potential measurements for each layer of coating are 
presented in Appendix J, the results are summarized in Table 8 and a plot is 
- 
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provided as illustration of inversion of surface charge after each successive 
coating (Figure 52). The UV plasmon band shift was recorded and summarized 
in Figure 53. It is shown that coating with TNF- did not cause an increase in 
overall size of the Au NP which is in agreement with what we observed in the 
TEM (Figure 53). In fact, coating with TNF- provided spatial separation in the 
NPs. However, once first layer chitosan coating was introduced, we saw a shift of 
~25 nm in the uv plasmon band, indicating there was probably an increase in 
particle size or aggregation of the particles. We validated on TEM and concluded 
that the coating layer caused an overall increase in size of the nanocomplexes by 
~4 nm and at the same time induced some aggregation in the system. 
Subsequent coating with heparin further shifted the plasmon band by ~5 nm but 
we did not see any drastic increase in overall size of nanocomplexes (Figure 54).  
From the TEM, we observed the particles started to aggregate slightly that 
probably was the reason for the plasmon band shift. We next introduced another 
layer of chitosan coating to the particles and observed that second layer of 
chitosan coating only caused 1 nm shift in plasmon band. Again, we did not 
observe any increase in overall size of the Au NPs. However, we did see similar 
aggregation patterns as in the heparin coating. As so, the coating was stopped 
after second layer of chitosan was introduced on the nanocomplexes. These 
nanocomplexes formulation was used for the cell viability assessment and animal 
testing experiments. 
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Figure 50. Absorbance spectra of Au NP coated with different concentration of 
MDS. 
 
 
Table 6. Plasmon band peak of MDS Coating 
Sample Plasmon band peak absorption (nm) 
Au 520 
Au-MDS-10 mg 522 
Au-MDS-25 mg 525 
Au-MDS-50 mg 525 
Au-MDS-75 mg 525 
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Table 7. Plasmon band peak with varying concentration of NaCl 
Sample Abs (nm) 
Au 520 
Au-MDS-10 mg 522 
Au-MDS-1 mM NaCl 522 
Au-MDS-10 mM NaCl 522 
Au-MDS-25 mM NaCl 522 
Au-MDS-50 mM NaCl 522 
Au-MDS-75 mM NaCl 526 
Au-MDS-100 mM NaCl 530 
 
 
 
 
Figure 51. Absorbance spectra of Au NP in different concentration of NaCl.  
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Table 8. Summary of zeta potential and plasmon band peak of each layer of 
coating 
Sample Zeta Potential (mV) Abs (nm) 
Au NP  520 
Au-MDS  -53.00  1.37 522 
Au-MDS-TNF  -20.60  1.42 524 
Au-MDS-TNF-C1  +44.24  0.81 549 
Au-MDS-TNF-C1H1  -44.18  0.48 554 
Au-MDS-TNF-C2H1  +48.80  0.77 555 
Au-MDS-TNF-C1Heparin-QD710  -25.08  0.78 - 
Au-MDS-TNF-C2Heparin-QD710 +31.84  1.35 - 
 
 
 
Figure 52. Zeta potential measurement of layer-by-layer nanocomplexes. 
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Figure 53. Absorbance spectra of Au NP coated with chitosan and heparin. 
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Figure 54. TEM of (a) Au NP; (b) Au-MDS; (c) Au-MDS-TNF; (d) Au-MDS-TNF-
C1. (e) Au-MDS-TNF-C1H1. (f) Au-MDS-TNF-C2H1. 
 
 
(a) (b) 
(c) (d) 
(e) (f) 
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6.3.5.  Cell viability and animal testing 
WEHI-13VAR is a stable variant of WEHI 164 clone 13 fibrosarcoma that 
is sensitive towards TNF- (Espevik et al. 1986,Khabar, 1995 #11). Here, we 
used WEHI-13VAR for our cytotoxicity analysis of the encapsulated TNF- in the 
nanocomplexes. We first generated a calibration curve for a series of TNF- 
concentration. We performed MTS assay to assess the amount of TNF- coated 
on Au NPs against the standard curve (Figure 55). From Figure 56, we found that 
the amount of TNF- coated on Au-MDS-TNF was about 0.1 % of the feed 
concentration regardless of the feed concentrations (Table 9). This could 
possibly be due to the limitation of the surface area and surface ligand available 
for the TNF- complexation to take place. We further conducted the evaluation of 
the release of TNF- from the nanocomplexes with different layers of coating 
(Figure 57). We saw an increase inhibition of the release of TNF- as the number 
of layers of coating increases. The polyelectrolytes layers could partially prevent 
the release of TNF- but not totally inhibiting the crossing out from the 
nanocomplexes. When Au-MDS-TNF-C2H1 nanocomplexes were subjected to 
incubation with chitosanse at a concentration of 2 U/mL for 2 h, the 
nanocomplexes degraded and release all the TNF- coated on the Au NPs. At 
the same time, we did a control test to treat the WEHI-13VAR cells with 2 U/mL 
of chitosanase and found that it has no toxicity effect on the cells. Similarly, no 
toxicity effect was also detected for cells treated with Au-MDS. 
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We next conducted a preliminary testing by administering Au-MDS-TNF, 
Au-MDS-TNF-C1 and Au-MDS-TNF-C1H1 nanocomplexes in the footpad of 
nude mice and isolated the popiteal lymph node 24 h post injection. We found 
that we could only visualize the red color of the Au nanocomplexes with the 
series of mice treated with Au-MDS-TNF but not with the other nanocomplexes 
(Figure 58). On the contrary, brightfield images of the cryo-sectioned of the 
lymph nodes further indicated that Au-MDS-TNF nanocomplexes were densely 
observed in the sinusoids of the lymph nodes (Figure 59b) but only traces of the 
particles can be found the samples treated with Au-MDS and Au-MDS-TNF-C1 
(Figure 59 a and c). The absence of Au-MDS-TNF-C1H1 in the lymph nodes 
probably mean that the nanocomplexes either could not reach the lymph nodes 
or they were totally dispersed in the lymph nodes such that they were too sparse 
to be detected here. Interestingly, we did not notice any significant enlargement 
in the treated lymph nodes (Table 10).  
Prior to conducting the in vivo imaging we performed a screening of the 
QD710-labeled heparin and also AlexaFluo 790-labeled chitosan to evaluate the 
fluorescent signals with various filters available on the IVIS system. As illustrated 
in Figure 60, it was shown QD-labeled heparin can be excited with 570-710 nm 
source and the signal can be recorded using with Cy5.5 and ICG filters.  On the 
other hand, AlexaFluo 790-chitosan can only be excited using 640-710 nm 
source and the signal can only be captured with ICG filter.  
Subsequently we continued to in vivo testing on the IVIS system to track 
the fluorescent signals of series nanocomplexes.  We injected nanocomplexes 
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that were coated with QD-labeled heparin (Au-MDS-TNF-C2-HepQD710) and 
AlexaFluo 790-labled chitosan (Au-MDS-TNF-C1-HepQD710-ChitAF790). We 
included commercial QD800-NH2 in this study as positive control (Figure 61). We 
monitored the animals are different time points and the images are as in Figure 
62 and 63. We first started to observe fluorescent signal of QD800-NH2 in the 
popiteal lymph node region at 40 min but not for the animals tested with 
nanocomplexes. At 90 min post-injection we started to see a decrease in the 
fluorescent signal by almost half in the footpad for the mice treated with 
nanocomplexes. However, we did not see any signal near the popiteal lymph 
nodes region and we no longer can detect any signal 24 h post-injection. We 
isolated the popiteal lymph nodes and did an ex vivo imaging on it. We found 
slight traces of fluorescent signal but it was very much lower than the signal at 
the start of the experiment. We speculate that some of the nanocomplexes 
traversed through the lymphatic vessels and accumulated at the popiteal lymph 
nodes 24 h post treatment. However, since nude mice lack of T-cells we are 
unclear if this could attribute to dictate the route of delivery of these 
nanocomplexes. Other possible explanations could be that the nanocomplexes 
might have being degraded by heparinase present in the body of the mice when 
the nanocomplexes traverse to the lymph nodes or the nanocomplexes have 
traveled further to other lymph nodes and we could detect the signal due to 
dilution.  
In addition, to address if the nanocomplexes remained intact while being 
delivered to the lymph nodes, we carried out an ex vivo fluorescence resonance 
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energy transfer (FRET) analysis on the lymph nodes that were isolated from mice 
treated with Au-MDS-TNF-C1-HepQD710-ChitAF790 nanocomplexes. FRET is a 
distance-dependent interaction between the excited states of two fluorescent 
molecules whereby excitation from donor molecule is transferred to acceptor 
molecule without emission of a photon. In our current study, QD710 and AlexFluo 
790 are the donor and acceptor molecules respectively. As depicted in Figure 64, 
if the nanocomplexes are stable while being delivered to the lymph nodes, we will 
expect to be able to record the fluorescent signal of AlexaFluo 790 only with ICG 
filter when excited with 570 or 605 nm source. When excited with 570 or 605 nm 
source fluorescent signal from QD710 can be detected using either Cy5.5 or ICG 
filter if the nanocomplexes degraded. Presented in Figure 65 are the results of 
the analysis of the lymph nodes using different excitation/emission filter sets. As 
shown (a) and (c), traces of fluorescent signals were observed with both 605/ICG 
and 570/ICG filters but no fluorescent signal was recorded on 605/Cy5.5 and 
570/Cy5.5 filters. This probably suggests that the nanocomplexes still remain 
intact 24 h post-injection and were delivered to the lymph nodes. Nevertheless, 
the signal recorded after 24 h was lower than at the start of the experiment, more 
detailed experiments are needed to determine the fraction of nanocomplexes 
were delivered and also to address if it is possible that the nanocomplexes have 
traversed to other lymph nodes.   
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Figure 55. Standard calibration curve of cell viability of WEHI-13VAR cells with 
dose of TNF-. 
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Figure 56. MTS cell viability of Au-MDS coated with different amount of TNF-. 
 
 
 
Table 9. Estimated amount of coating of TNF- on 1 mL of Au NPs 
Feed Coating Concentration  
(ng) 
Calculated Coating Concentration 
(ng) 
10 0.062 
20 0.064 
50 0.069 
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Figure 57. MTS cell viability of WEHI-13VAR cells treated with nanocomplexes 
with different coating.  
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Figure 58. Popiteal lymph nodes of mice treated with nanocomplexes. (a) 
Control. (b) Au-MDS-TNF. (c) Au-MDS-TNF-C1. (d) Au-MDS-TNF-C1H1. 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
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Figure 59. Brightfield images of cryo-sectioned of popiteal lymph nodes of mice 
treated with nanocomplexes. (a) Au-MDS. (b) Au-MDS-TNF. (c) Au-MDS-TNF-
C1. (d) Au-MDS-TNF-C1H1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
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Table 10. Mass of lymph nodes treated with nanocomplexes 
Sample Treated (mg) Untreated (mg) 
No injection 2.1 2.3 
Au-MDS 2.0 2.1 
Au-MDS-TNF-1 2.6 3.1 
Au-MDS-TNF-2 3.2 2.3 
Au-MDS-TNF-3 2.1 1.4 
Au-MDS-TNF-Chitosan-1 2.8 2.7 
Au-MDS-TNF-Chitosan-2 3.6 2.1 
Au-MDS-TNF-Chitosan-Heparin-1 1.3 1.6 
Au-MDS-TNF-Chitosan-Heparin-2 1.5 1.1 
Au-MDS-TNF-Chitosan-Heparin-3 2.2 2.3 
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Figure 60. Imaging of (a) QD710-heparin and (b) AlexaFluo790-chitisan with 
different excitation/emission filter. (i) 710/ICG; (ii) 675/ICG; (iii) 640/ICG; (iv) 
605/ICG; (v) 570/ICG; (vi) 605/Cy5.5; (vii) 570/Cy5.5. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(i) 
(Iiji
ma) 
(iii) 
(iv) 
(v) 
(vi) 
(vii) 
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Figure 61. In vivo imaging of commercial QD800-NH2 after footpad injection.  
The mice were anesthetized, injected with 20 L  of 0.16 M of QDs and the 
fluorescence was measured with the IVIS Kinetic using filter sets 710/820 
(Ex/Em). The fluorescence pattern was analyzed at different time interval post-
injection, (a) 0 hr, (b) 40 min, (c) 90 min, (d) 24 h, (e) popiteal lymph nodes, (f) 
popiteal lymph nodes imaged with 605/ICG filters. 
(a) (b) 
(c) (d) 
(e) 
(f) 
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Figure 62. In vivo imaging of Au-MDS-TNF-C2-HepQD710 nanocomplexes after 
footpad injection.  The mice were anesthetized, injected with 20 L  of 
nanocomplexes and the fluorescence was measured with the IVIS Kinetic using 
filter sets 710/820 (Ex/Em). The fluorescence pattern was analyzed at different 
time interval post-injection, (a) 0 hr, (b) 40 min, (c) 90 min, (d) 24 h, (e) popiteal 
lymph nodes.  
(e) 
(a) (b) 
(c) (d) 
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Figure 63. In vivo imaging of Au-MDS-TNF-C2-HepQD710-ChitAF790 
nanocomplexes after footpad injection.  The mice were anesthetized, injected 
with 20 L  of nanocomplexes and the fluorescence was measured with the IVIS 
Kinetic using filter sets 710/820 (Ex/Em). The fluorescence pattern was analyzed 
at different time interval post-injection, (a) 0 hr, (b) 90 min, (c) 24 h, (c) popiteal 
lymph nodes.  
(a) (b) 
(c) (d) 
(e) 
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Figure 64. Schematic of QD-FRET analysis. 
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Figure 65. Ex vivo QD-FRET analysis of popiteal lymph nodes of mice injected 
with Au-MDS-TNF-C2-HepQD710-ChitAF790 nanocomplexes with different 
excitation/emission filter sets. (a) 605/ICG, (b) 605/Cy5.5, (c) 570/ICG, (d) 
570/Cy5.5. 
 
 
 
 
 
(a) (b) 
(c) (d) 
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6.4 Conclusion 
In summary, we have successfully conjugated QD710 to heparin, 
AlexaFluo 790 to chitosan and formulated nanocomplexes to encapsulate TNF- 
for delivery to the lymph nodes. In the animal testing we could not detect strong 
QD-FRET signal 24 h post-injection possibly due to lack of T-cells in nude mice 
that affected the delivery mechanism, the nanocomplexes might have partially 
degraded along the delivery route, or the nanocomplexes might have traversed 
further to other lymph nodes such that the nanocomplexes were too dilute for 
detecting. Further experiments are needed for confirmation.  
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Chapter 7 
 
Conclusion and Future Direction 
 
Quantum dots (QDs) are attractive for several biological applications. 
However, the challenge comes from developing biocompatible and heavy-metal 
free QDs. The goal of this dissertation was to design novel water-soluble, near-
infrared emitting quantum dots that have the feasibility for surface modification to 
append bioactive moieties. Specifically, a biocompatible stabilizing ligand, L-
glutathione was used to serve this purpose. Effort was made to elucidate the in 
vivo biodistribution and the outcome was different from the results reported for 
conventional QDs. Our QDs interestingly are found to be sequestered in the 
stomach in vivo. The underlying mechanism of QDs accumulating in the stomach 
is still unknown and further studies are required to address this observation.  
We also exploited the uniqueness of the stabilizer and appended targeting 
moiety to the QDs and performed cellular study to validate the utility of QDs for 
cell specificity applications. From the imaging results we concluded that the 
surface modification chemistry was successful and this would open up further 
exploration for various targeting applications. We further explore the feasibility of 
using our QDs as nanoprobe for delivery to the lymph node. However, the results 
we obtained were not as expected; only a small portion nanoprobe was delivered 
to the lymph node. More experiments would be needed to address the delivery 
mechanisms in order to optimize the design of the nanoprobe for lymph node 
delivery study.   
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Potential research directions that can be stem from this work include: (1) a 
detailed investigation of the mechanism of the unusual in vivo biodistribution; (2) 
incorporation of multifunctionalities onto the surface of QDs to produce 
nanoprobes that can achieve simultaneous treatment and diagnosis; (3) precise 
engineering of the QDs as nanoprobes for real time in vivo tracking of drug 
delivery mechanisms and efficacies that can possible lead to better drug carrier 
designs in the future.  
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Appendix A: Stablizer selection 
 
 
 
 
St Zn(OAc)2 
(mmol) 
NaHSe 
(mmol) 
St       
(mmol) 
Emax        (nm) 
Cys 0.5 0.2 0.6 QDs ppt 
CA 0.5 0.2 0.6 No QDs formed 
GSH 0.5 0.2 0.6 385 
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Appendix B: Dopant selection 
 
 
 
 
Dopant Zn(OAc)2 
(mmol) 
Dopant 
(mmol) 
NaHSe 
(mmol) 
GSH 
(mmol) 
Temp 
(C) 
Emax  
(nm) 
Cu(OAc)2 0.5 0.005 0.2 0.6 95 436 
AgOAc 0.5 0.005 0.2 0.6 RT 648 
Au(OAc)3 0.5 0.005 0.2 0.6 RT/95 No QDs 
formed 
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Appendix C: Effect of pH on rate of reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pH 5 pH 6 pH 7 
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Appendix D: Effect of Zn(OAc)2 on rate of reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 mmol 5 mmol 7.5 mmol 
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Appendix E: Effect of AgOAC on rate of reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.05 mmol 0.10 mmol 0.15 mmol 
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Appendix F: Effect of Se on rate of reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.4 mmol 0.8 mmol 0.6 mmol 
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Appendix G: Effect of L-GSH at pH 5 on rate of reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 mmol 15 mmol 12.6 mmol 
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Appendix H: Effect of L-GSH at pH 7 on rate of reaction 
 
6 mmol 12.6 mmol 10 mmol 12.6 mmol 
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Appendix I: Cryo-section of stomach where QD710 was detected 
 
(Slice 1) 
 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
(c) 
(a) 
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(Slice 2) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
(c) 
(a) 
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(Slice 4) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 5) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
149 
 
(Slice 6) 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 7) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
(b) 
(a) 
(c) 
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(Slice 8) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 9) 
   
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 10) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 13) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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(Slice 14) 
 
 
(a) Confocal image with 561 nm excitation source and observed with red filter. (b) 
Overlaps of brightfield and red filter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) (a) 
(c) 
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Appendix J: Zeta potential distribution of LbL study 
 
 
Zeta potential of Au-MDS 
 
 
 
Zeta potential of Au-MDS-TNF 
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Zeta potential of Au-MDS-TNF-C1 
 
 
 
Zeta potential of Au-MDS-TNF-C1-H1 
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Zeta potential of Au-MDS-TNF-C2-H1 
 
 
 
Zeta potential of Au-MDS-TNF-C1-Heparin-QD710 
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Zeta potential of Au-MDS-TNF-C2-Heparin-QD710 
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